Calcitonin gene-related peptide (CGRP) and its role in hypertension
Hypertension is still presently the number one “silent killer” in the Western World, and a major risk factor for the development of secondary diseases contributing to cardiovascular disease (CVD). However, despite a broad range of therapies, the mechanisms involved in the onset of hypertension remai...
Saved in:
| Published in | Neuropeptides (Edinburgh) Vol. 45; no. 2; pp. 93 - 104 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Kidlington
Elsevier Ltd
01.04.2011
Elsevier |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0143-4179 1532-2785 1532-2785 |
| DOI | 10.1016/j.npep.2010.12.002 |
Cover
| Abstract | Hypertension is still presently the number one “silent killer” in the Western World, and a major risk factor for the development of secondary diseases contributing to cardiovascular disease (CVD). However, despite a broad range of therapies, the mechanisms involved in the onset of hypertension remains unclear, therefore there is a real need to investigate the mechanisms involved. Calcitonin gene-related peptide (CGRP) is the most potent microvascular vasodilator known to date. Widely expressed in the nervous system, this peptide is considered to play a positive role in wound healing and protects against ischaemic and other traumas. However, whilst the protective mechanisms are not well understood, evidence indicates that these mechanisms become important in vascular-related stress. This review provides evidence that CGRP is both a potent vasodilator and hypotensive agent. However studies to date suggest that CGRP does not contribute to the physiological regulation of blood pressure. By comparing results from a range of human and animal studies, findings broadly suggest an association between CGRP and the pathophysiology of hypertension in terms of protective mechanisms, with possibly the RAMP1 component of the CGRP receptor playing a key role in the brain stem, in addition to peripheral receptors. The studies of agents that release CGRP agonists are at an early stage, with analogues for human use currently under development. However, at this stage, further research is required to establish the mechanisms by which CGRP is protective in the onset of hypertension, if novel and therapeutic modes of treatment are to be developed. |
|---|---|
| AbstractList | Hypertension is still presently the number one “silent killer” in the Western World, and a major risk factor for the development of secondary diseases contributing to cardiovascular disease (CVD). However, despite a broad range of therapies, the mechanisms involved in the onset of hypertension remains unclear, therefore there is a real need to investigate the mechanisms involved. Calcitonin gene-related peptide (CGRP) is the most potent microvascular vasodilator known to date. Widely expressed in the nervous system, this peptide is considered to play a positive role in wound healing and protects against ischaemic and other traumas. However, whilst the protective mechanisms are not well understood, evidence indicates that these mechanisms become important in vascular-related stress. This review provides evidence that CGRP is both a potent vasodilator and hypotensive agent. However studies to date suggest that CGRP does not contribute to the physiological regulation of blood pressure. By comparing results from a range of human and animal studies, findings broadly suggest an association between CGRP and the pathophysiology of hypertension in terms of protective mechanisms, with possibly the RAMP1 component of the CGRP receptor playing a key role in the brain stem, in addition to peripheral receptors. The studies of agents that release CGRP agonists are at an early stage, with analogues for human use currently under development. However, at this stage, further research is required to establish the mechanisms by which CGRP is protective in the onset of hypertension, if novel and therapeutic modes of treatment are to be developed. Hypertension is still presently the number one "silent killer" in the Western World, and a major risk factor for the development of secondary diseases contributing to cardiovascular disease (CVD). However, despite a broad range of therapies, the mechanisms involved in the onset of hypertension remains unclear, therefore there is a real need to investigate the mechanisms involved. Calcitonin gene-related peptide (CGRP) is the most potent microvascular vasodilator known to date. Widely expressed in the nervous system, this peptide is considered to play a positive role in wound healing and protects against ischaemic and other traumas. However, whilst the protective mechanisms are not well understood, evidence indicates that these mechanisms become important in vascular-related stress. This review provides evidence that CGRP is both a potent vasodilator and hypotensive agent. However studies to date suggest that CGRP does not contribute to the physiological regulation of blood pressure. By comparing results from a range of human and animal studies, findings broadly suggest an association between CGRP and the pathophysiology of hypertension in terms of protective mechanisms, with possibly the RAMP1 component of the CGRP receptor playing a key role in the brain stem, in addition to peripheral receptors. The studies of agents that release CGRP agonists are at an early stage, with analogues for human use currently under development. However, at this stage, further research is required to establish the mechanisms by which CGRP is protective in the onset of hypertension, if novel and therapeutic modes of treatment are to be developed.Hypertension is still presently the number one "silent killer" in the Western World, and a major risk factor for the development of secondary diseases contributing to cardiovascular disease (CVD). However, despite a broad range of therapies, the mechanisms involved in the onset of hypertension remains unclear, therefore there is a real need to investigate the mechanisms involved. Calcitonin gene-related peptide (CGRP) is the most potent microvascular vasodilator known to date. Widely expressed in the nervous system, this peptide is considered to play a positive role in wound healing and protects against ischaemic and other traumas. However, whilst the protective mechanisms are not well understood, evidence indicates that these mechanisms become important in vascular-related stress. This review provides evidence that CGRP is both a potent vasodilator and hypotensive agent. However studies to date suggest that CGRP does not contribute to the physiological regulation of blood pressure. By comparing results from a range of human and animal studies, findings broadly suggest an association between CGRP and the pathophysiology of hypertension in terms of protective mechanisms, with possibly the RAMP1 component of the CGRP receptor playing a key role in the brain stem, in addition to peripheral receptors. The studies of agents that release CGRP agonists are at an early stage, with analogues for human use currently under development. However, at this stage, further research is required to establish the mechanisms by which CGRP is protective in the onset of hypertension, if novel and therapeutic modes of treatment are to be developed. Abstract Hypertension is still presently the number one “silent killer” in the Western World, and a major risk factor for the development of secondary diseases contributing to cardiovascular disease (CVD). However, despite a broad range of therapies, the mechanisms involved in the onset of hypertension remains unclear, therefore there is a real need to investigate the mechanisms involved. Calcitonin gene-related peptide (CGRP) is the most potent microvascular vasodilator known to date. Widely expressed in the nervous system, this peptide is considered to play a positive role in wound healing and protects against ischaemic and other traumas. However, whilst the protective mechanisms are not well understood, evidence indicates that these mechanisms become important in vascular-related stress. This review provides evidence that CGRP is both a potent vasodilator and hypotensive agent. However studies to date suggest that CGRP does not contribute to the physiological regulation of blood pressure. By comparing results from a range of human and animal studies, findings broadly suggest an association between CGRP and the pathophysiology of hypertension in terms of protective mechanisms, with possibly the RAMP1 component of the CGRP receptor playing a key role in the brain stem, in addition to peripheral receptors. The studies of agents that release CGRP agonists are at an early stage, with analogues for human use currently under development. However, at this stage, further research is required to establish the mechanisms by which CGRP is protective in the onset of hypertension, if novel and therapeutic modes of treatment are to be developed. |
| Author | Brain, Susan D. Smillie, Sarah-Jane |
| Author_xml | – sequence: 1 givenname: Sarah-Jane surname: Smillie fullname: Smillie, Sarah-Jane – sequence: 2 givenname: Susan D. surname: Brain fullname: Brain, Susan D. email: sue.brain@kcl.ac.uk |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23896348$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21269690$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkl1rFDEYhYNU7Lb6B7yQuRHrxaz5mMxmRIQyaC0UFD-uQyZ5R7NmkzHJCvvvzbDbCoVWrwLhOSd5z3lP0JEPHhB6SvCSYNK-Wi_9BNOS4vmCLjGmD9CCcEZruhL8CC0waVjdkFV3jE5SWmOMGyrEI3RMCW27tsML1PfKaZuDt776Dh7qCE5lMFVxztZAddZffP70slLeVDanKgYHVWF_7CaIGXyywT9GD0flEjw5nKfo2_t3X_sP9dXHi8v-_KrWnLJcw4B1pwUZ1Ig5VaYRXasArwQM3BBFFIBh7aA6xkahm64TzHAyNkJTzTnD7BS92PtOMfzaQspyY5MG55SHsE1ScNHMYfD_IGmHW4FJIZ8dyO2wASOnaDcq7uR1QgV4fgBU0sqNUXlt01-OlSlYIwpH95yOIaUI4w1CsJzrkms51yXnH0pCZamriMQtUelC5ZJpjsq6-6Vv9lIoif-2EGXSFrwGYyPoLE2w98vf3pJrZ70tE_6EHaR12EZfupREpiKQX-ZVmjeJlCUihM-5vL7b4F-v_wF_MdZL |
| CODEN | NRPPDD |
| CitedBy_id | crossref_primary_10_3390_biomedicines11071864 crossref_primary_10_1186_s10194_018_0869_8 crossref_primary_10_1016_j_ejphar_2012_01_028 crossref_primary_10_1016_j_mehy_2013_04_025 crossref_primary_10_1097_HJH_0000000000003440 crossref_primary_10_1007_s44200_021_00005_7 crossref_primary_10_3390_jcm10071429 crossref_primary_10_1016_j_arcmed_2022_12_002 crossref_primary_10_3892_ijmm_2017_3002 crossref_primary_10_1161_HYPERTENSIONAHA_120_14851 crossref_primary_10_14814_phy2_15150 crossref_primary_10_1111_head_14336 crossref_primary_10_2174_1570159X18666200503223240 crossref_primary_10_1111_head_13684 crossref_primary_10_1177_0333102420949858 crossref_primary_10_3389_fphar_2024_1425863 crossref_primary_10_3892_etm_2017_5126 crossref_primary_10_3390_ijms232113408 crossref_primary_10_4103_ajprhc_ajprhc_4_22 crossref_primary_10_1016_j_tips_2013_05_007 crossref_primary_10_2217_pmt_2021_0077 crossref_primary_10_3390_biology10080783 crossref_primary_10_1007_s00281_018_0673_1 crossref_primary_10_1056_NEJMc1716990 crossref_primary_10_2147_VHRM_S388257 crossref_primary_10_1002_biof_1037 crossref_primary_10_1016_j_tips_2016_06_002 crossref_primary_10_1016_j_neuroscience_2016_06_012 crossref_primary_10_1134_S0006350922040200 crossref_primary_10_1136_jnnp_2020_324674 crossref_primary_10_1097_MD_0000000000024741 crossref_primary_10_3389_fneur_2024_1399792 crossref_primary_10_1016_j_diabres_2017_06_026 crossref_primary_10_1152_physrev_00059_2021 crossref_primary_10_12677_acm_2024_1492442 crossref_primary_10_1016_j_mce_2015_01_010 crossref_primary_10_17116_jnevro201911911174 crossref_primary_10_1038_mi_2014_80 crossref_primary_10_1074_jbc_M116_751362 crossref_primary_10_1242_jeb_070177 crossref_primary_10_1038_s41598_019_44333_w crossref_primary_10_1080_13543784_2019_1618830 crossref_primary_10_1016_S0140_6736_25_00109_6 crossref_primary_10_1371_journal_pone_0108909 crossref_primary_10_1007_s10735_020_09903_7 crossref_primary_10_1111_bph_13799 crossref_primary_10_1177_0268355519855598 crossref_primary_10_1155_2016_2056786 crossref_primary_10_3390_biom13050838 crossref_primary_10_1007_s10620_012_2362_6 crossref_primary_10_3390_jcm13185616 crossref_primary_10_1111_joa_13877 crossref_primary_10_1186_s10194_024_01769_4 crossref_primary_10_3389_fphys_2018_01167 crossref_primary_10_1016_j_cbpa_2012_10_038 crossref_primary_10_1007_s10753_021_01591_z crossref_primary_10_1007_s11055_015_0109_5 crossref_primary_10_1080_14656566_2022_2057221 crossref_primary_10_3389_fphys_2018_01249 crossref_primary_10_1016_j_mocell_2024_100030 crossref_primary_10_1016_j_npep_2014_11_004 crossref_primary_10_1111_head_14679 crossref_primary_10_1152_physrev_00034_2013 crossref_primary_10_1007_s11916_022_01064_4 crossref_primary_10_1016_j_jdiacomp_2015_05_005 crossref_primary_10_1111_1440_1681_12248 crossref_primary_10_3390_ph16121683 crossref_primary_10_1155_2020_7869403 crossref_primary_10_1016_j_ejphar_2012_01_015 crossref_primary_10_1021_acs_biochem_7b00077 crossref_primary_10_1155_2018_2109352 crossref_primary_10_1021_acschemneuro_8b00611 crossref_primary_10_18632_oncotarget_12182 crossref_primary_10_1016_j_jprot_2013_05_034 crossref_primary_10_1016_j_regpep_2011_05_014 crossref_primary_10_1111_bph_16372 crossref_primary_10_5334_jcr_185 crossref_primary_10_1007_s10072_019_03786_7 crossref_primary_10_1177_0333102419856640 crossref_primary_10_3892_br_2012_26 crossref_primary_10_1016_j_bspc_2022_104222 crossref_primary_10_1016_j_euprot_2015_07_008 crossref_primary_10_1016_j_mvr_2019_103889 crossref_primary_10_1177_03331024221103509 crossref_primary_10_1016_j_regpep_2013_06_008 crossref_primary_10_1161_HYPERTENSIONAHA_113_02517 crossref_primary_10_1007_s11916_018_0686_4 crossref_primary_10_1152_ajprenal_00434_2012 crossref_primary_10_3390_math11153307 crossref_primary_10_3109_10520295_2014_902503 crossref_primary_10_1177_1756286420927119 crossref_primary_10_1038_s41598_024_77520_5 crossref_primary_10_25207_1608_6228_2024_31_6_40_55 |
| Cites_doi | 10.1016/j.peptides.2008.06.010 10.1016/j.ejphar.2005.12.039 10.1016/S0014-2999(00)00407-6 10.1080/13697130802378493 10.1016/0014-2999(87)90073-2 10.1038/sj.ki.5002303 10.1006/mcne.1999.0767 10.1021/bi0102860 10.3109/08037059209077667 10.1038/344770a0 10.1196/annals.1367.008 10.1124/jpet.109.155143 10.1073/pnas.82.15.5064 10.1152/physrev.00037.2003 10.1016/0014-5793(86)81091-2 10.1007/BF03165805 10.1016/0014-2999(85)90456-X 10.1016/S0140-6736(10)60323-6 10.1016/0024-3205(86)90568-0 10.1006/bbrc.1999.1943 10.1124/jpet.110.165993 10.1097/01.hjh.0000125409.50839.f1 10.1124/mol.55.6.1054 10.1097/00004647-200205000-00014 10.1093/cvr/27.8.1477 10.2217/14622416.8.7.687 10.1016/S0378-5122(98)00047-4 10.1210/edrv-17-5-533 10.2337/diabetes.40.8.948 10.1152/ajpheart.1999.276.1.H284 10.1016/S0196-9781(98)00066-7 10.1038/sj.jhh.1001294 10.1111/j.1745-7254.2005.00057.x 10.1038/sj.bjp.0701986 10.1042/bst0300451 10.7326/0003-4819-139-9-200311040-00011 10.1111/j.1476-5381.1985.tb11107.x 10.1016/S0014-5793(00)02259-6 10.1016/0196-9781(92)90067-D 10.1111/j.1440-1681.2007.04703.x 10.1016/0006-291X(90)90621-S 10.1161/01.ATV.0000217611.81085.c5 10.1111/j.1476-5381.2009.00541.x 10.1016/0006-291X(86)90708-4 10.1021/bi002497v 10.1111/j.1751-7176.2009.00123.x 10.1111/1523-1747.ep12455620 10.1111/j.1474-8673.1991.tb00317.x 10.1021/bi0347508 10.1038/288373a0 10.1016/0090-6980(76)90014-9 10.1002/ana.410230214 10.1161/01.RES.53.2.121 10.1161/01.HYP.29.1.248 10.1016/S0140-6736(05)67483-1 10.1385/JMN:22:1-2:105 10.3109/07420529309073886 10.1016/S0021-9258(19)75816-5 10.1038/30666 10.1016/0306-4522(88)90018-8 10.1073/pnas.0705974104 10.1016/j.ejphar.2009.10.053 10.1111/j.1749-6632.1992.tb22759.x 10.1016/j.peptides.2005.02.002 10.1007/s12199-008-0040-2 10.1016/0304-3940(85)90166-1 10.1152/physrev.1990.70.4.921 10.1016/0304-3940(94)90615-7 10.1097/00004872-199210000-00017 10.1016/j.bbrc.2004.05.103 10.1038/sj.jhh.1001683 10.1056/NEJMoa030505 10.1007/s11906-007-0057-8 10.1161/01.HYP.0000168926.44648.ed 10.1097/00004872-199210120-00010 10.1016/0165-1838(94)90009-4 10.1291/hypres.26.S105 10.1038/sj.bjp.0706461 10.1038/335164a0 10.1002/ana.410280213 10.1074/jbc.271.19.11325 10.1161/01.HYP.29.4.945 10.2174/1381612043382855 10.1016/0306-3623(88)90002-X 10.1002/ana.410330109 10.1007/BF02554909 10.1080/140174398427965 10.1016/S1885-5857(09)72223-6 10.1161/HYPERTENSIONAHA.109.148171 10.1016/j.pain.2003.09.008 10.1124/mol.106.024257 10.1038/ncpcardio1091 10.1038/sj.bjp.0703110 10.1016/j.mcna.2009.02.014 10.1097/00004872-198812040-00131 10.1291/hypres.21.235 10.1016/0167-0115(86)90071-6 10.1006/bbrc.1995.1047 10.1006/bbrc.1993.1451 10.1016/S0014-5793(03)01250-X 10.1111/j.1475-097X.1996.tb00557.x 10.1161/01.HYP.35.1.470 10.1007/978-3-540-79090-7_11 10.1111/j.1476-5381.1990.tb14656.x 10.1074/jbc.M302571200 10.1016/0167-0115(88)90339-4 10.1161/HYPERTENSIONAHA.107.090084 10.1097/00004872-199409000-00012 10.1016/S0165-5728(02)00221-7 10.1007/BFb0033194 10.1124/jpet.108.144220 10.1097/HJH.0b013e328329bbd7 10.1021/bi020279r 10.1016/S0022-3565(25)12587-1 10.1152/ajprenal.90599.2008 10.1074/jbc.M305332200 10.1093/ajh/4.7.565 10.1161/hh2301.100812 10.1038/298240a0 10.1038/sj.bjp.0705040 10.1074/jbc.M109661200 10.1254/jjp.88.39 10.1097/00004872-198900076-00093 10.1177/0333102410362122 10.1126/science.1658940 10.1038/305534a0 10.1152/ajprenal.00280.2006 10.1093/brain/117.3.427 10.1080/08037050600996586 10.1093/ajh/6.5.434 10.1042/CS20050016 10.1038/sj.bjp.0707516 10.1007/s11655-001-0287-6 |
| ContentType | Journal Article |
| Copyright | 2011 Elsevier Ltd Elsevier Ltd 2015 INIST-CNRS Copyright © 2011 Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2011 Elsevier Ltd – notice: Elsevier Ltd – notice: 2015 INIST-CNRS – notice: Copyright © 2011 Elsevier Ltd. All rights reserved. |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7TK 8FD FR3 P64 RC3 |
| DOI | 10.1016/j.npep.2010.12.002 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Neurosciences Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Genetics Abstracts Engineering Research Database Technology Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Genetics Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry |
| EISSN | 1532-2785 |
| EndPage | 104 |
| ExternalDocumentID | 21269690 23896348 10_1016_j_npep_2010_12_002 S0143417910001150 1_s2_0_S0143417910001150 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: Biotechnology and Biological Sciences Research Council grantid: BB/E527098/1 – fundername: Medical Research Council |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFRF ABGSF ABIVO ABJNI ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRLJ AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDW HMK HMO HVGLF HZ~ IHE J1W KOM LX8 M29 M41 MO0 MOBAO N9A O-L O9- OAUVE OB0 ON- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SDF SDG SEL SES SEW SPCBC SSH SSN SSZ T5K UHS UNMZH WUQ Z5R ZGI ~G- AACTN AEHWI AFCTW AFKWA AJOXV AMFUW RIG SSU AADPK AAIAV ABLVK ABYKQ AJBFU DOVZS EFLBG LCYCR XFK AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7TK 8FD FR3 P64 RC3 |
| ID | FETCH-LOGICAL-c523t-eb0c9c81baf052ad4896ae078eb5d1a1aeed36ba933f8c49983d51f48c2c55303 |
| IEDL.DBID | AIKHN |
| ISSN | 0143-4179 1532-2785 |
| IngestDate | Thu Sep 04 19:47:56 EDT 2025 Fri Sep 05 08:13:47 EDT 2025 Mon Jul 21 05:56:25 EDT 2025 Mon Jul 21 09:15:40 EDT 2025 Tue Jul 01 05:29:21 EDT 2025 Thu Apr 24 22:56:58 EDT 2025 Fri Feb 23 02:34:28 EST 2024 Sun Feb 23 10:19:28 EST 2025 Tue Aug 26 16:33:37 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Hypertension Human Mouse Rat Sensory nerves CLR TRPV1 CGRP RAMP1 Rodentia Cardiovascular disease Calcitonin gene related peptide RAMP-1 protein Neuropeptide Vertebrata TRPV1 vanilloid receptor Mammalia Animal Sensory nerve |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2011 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c523t-eb0c9c81baf052ad4896ae078eb5d1a1aeed36ba933f8c49983d51f48c2c55303 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| PMID | 21269690 |
| PQID | 852906801 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_858420105 proquest_miscellaneous_852906801 pubmed_primary_21269690 pascalfrancis_primary_23896348 crossref_primary_10_1016_j_npep_2010_12_002 crossref_citationtrail_10_1016_j_npep_2010_12_002 elsevier_sciencedirect_doi_10_1016_j_npep_2010_12_002 elsevier_clinicalkeyesjournals_1_s2_0_S0143417910001150 elsevier_clinicalkey_doi_10_1016_j_npep_2010_12_002 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2011-04-01 |
| PublicationDateYYYYMMDD | 2011-04-01 |
| PublicationDate_xml | – month: 04 year: 2011 text: 2011-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Kidlington |
| PublicationPlace_xml | – name: Kidlington – name: Netherlands |
| PublicationTitle | Neuropeptides (Edinburgh) |
| PublicationTitleAlternate | Neuropeptides |
| PublicationYear | 2011 |
| Publisher | Elsevier Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
| References | Kyrou, Chrousos, Tsigos (b0360) 2006; 1083 Lundberg, Franco-Cereceda, Hua, Hökfelt, Fischer (b0410) 1985; 108 Oparil, Zaman, Calhoun (b0505) 2003; 139 Poyner, Sexton, Marshall, Smith, Quirion, Born (b0545) 2002; 54 Supowit, Zhao, Hallman, DiPette (b0625) 1997; 29 Petermann, Born, Chang, Fischer (b0520) 1987; 262 Li, Chen, Peng, Zhang, Li, Yuan, Hu, Deng, Li (b0370) 2009; 27 Simms, Hay, Bailey, Konycheva, Bailey, Wheatley (b0605) 2009; 41 Uren, Seydoux, Davies (b0670) 1993; 27 Tsujikawa, Yayama, Hayashi, Matsushita, Yamaguchi, Shigeno, Ogitani, Hirayama, Kato, Fukada, Takatori, Kawasaki, Okamoto, Ikawa, Okabe, Yamamoto (b0650) 2007; 104 Rovero, Giuliani, Maggi (b0575) 1992; 13 Sexton, Poyner, Simms, Christopoulos, Hay (b0600) 2009; 14 Uchiyamam, Shimizu, Nakagawa, Tanaka (b0655) 2008; 13 Lin, Harris, Flannery, Aruffo, Kaji, Gorn, Kolakowski, Lodish, Goldring (b0385) 1991; 254 Kuwasako, Kitamura, Nagoshi, Cao, Eto (b0355) 2003; 278 Roh, Chang, Bhalla, Klein, Hsu (b0570) 2003; 279 Lindstedt, Edvinsson, Edvinsson (b0400) 2006; 15 Edvinsson, Chan, Eftekhari, Nilsson, De Vries, Saveland, Dirven, Danser, MaassenVanDenBrink (b0130) 2010; 30 Márquez-Rodas, Longo, Rothlin, Balfagón (b0445) 2006; 62 Portaluppi, Vergnani, degli Uberti (b0535) 1993; 10 Moncada, Needleman, Bunting, Vane (b0465) 1976; 12 Carpenter, Schmidt, von Mentzer, Haglund, Roberts, Walpole (b0070) 2001; 40 Gupta, Harte, Sturdee (b0740) 2008; 11 Fraser, Wise, Brown, McLatchie, Main, Foord (b0185) 1999; 55 Goadsby, Edvinsson (b0235) 1993; 33 Li, Zhao, Supowit, DiPette, Wang (b0380) 2004; 22 Preibisz (b0550) 1993; 6 Wimalawansa (b0710) 1996; 17 Brain, Tippins, Morris, MacIntyre, Williams (b0040) 1986; 87 Portaluppi, Trasforini, Margutti, Vergnani, Ambrosio, Rossi (b0540) 1992; 10 (b0480) 2006 Djoussé, Mukamal (b0115) 2009; 62 Félétou, Vanhoutte (b0160) 2006; 26 Goadsby, Edvinsson (b0230) 1994; 117 Wang (b0680) 2005; 26 Holzer (b0275) 1992; 121 Oh-hashi, Shindo, Kurihara, Imai, Wang, Morita, Imai, Kayaba, Nishimatsu, Suematsu, Hirata, Yazaki, Nagai, Kuwaki, Kurihara (b0490) 2001; 89 Sabharwal, Zhang, Lu, Abboud, Russo, Chapleau (b0585) 2010; 55 Furchgott, Zawadzki (b0195) 1980; 27 Thomas, Dubner, Ruda (b0645) 1994; 171 Chan, Edvinsson, Eftekhari, Kimblad, Kane, Lynch, Hargreaves, de Vries, Garrelds, van den Bogaerdt, Danser, Maassenvandenbrink (b0080) 2010; 334 Juhasz, Zsombok, Modos, Olajos, Jakab, Nemeth, Szolcsanyi, Vitrai, Bagdy (b0300) 2003; 106 Lemne, Lundeberg, Theodorsson, Faire (b0745) 1994; 12 Gujer, Aldecoa, Buhlmann, Leuthauser, Muff, Fischer, Born (b0255) 2001; 40 Mulvany, Aalkjaer (b0475) 1990; 70 Chai, Mehrotra, Jan Danser, Schoemaker (b0075) 2006; 531 Olesen, Diener, Husstedt, Goadsby, Hall, Meier, Pollentier, Lesko (b0495) 2004; 350 Qi, Hay (b0555) 2010; 159 Meens, Fazzi, van Zandvoort, De Mey (b0460) 2009; 331 Kawasaki, Takasaki, Saito, Goto (b0320) 1988; 335 Goodman, Iversen (b0250) 1986; 38 Edvinsson, Gulbenkian, Barroso, Cunha, Polak, Mortensen, Jorgensen, Jansen-Olsen (b0140) 1998; 19 Gardiner, Compton, Kemp, Bennett, Bose, Foulkes, Hughes (b0215) 1991; 40 Bennett, Garrett, Diemel, Brain, Tomlinson (b0025) 1998; 124 Brain, Grant (b0045) 2004; 84 Kjartansson, Dalsgaard (b0340) 1987; 142 Ando, Pegram, Frolich (b0020) 1990; 258 Kitamura, Kangawa, Kawamoto, Ichiki, Nakamura, Matsuo, Eto (b0330) 1993; 192 Bühlmann, Aldecoa, Leuthäuser, Gujer, Muff, Fischer, Born (b0060) 2000; 486 Edvinsson, Ekman, Thulin (b0150) 1989; 7 Quirion, Van Rossum, Dumont, St Pierre, Fournier (b0560) 1992; 657 Steiner, Born, Fischer, Muff (b0615) 2003; 555 Wu, Eberlein, Rudolf, Engel, Hallermayer, Doods (b0720) 2000; 400 Susic, Frohlich (b0630) 2008; 5 Wang, Liu, Liu, Wen, Wen, Liu, Chen, Wu (b0690) 2007; 35 Branca, F., Nikogosian, H., Lobstein, T. 2007. The challenge of obesity in the WHO European Region and the Strategies for Response. Burg, Zahm, Knuepfer (b0065) 1994; 50 Crossman, Dashwood, Brain, McEwan, Pearson (b0095) 1990; 99 Goadsby, Edvinsson, Ekman (b0240) 1990; 28 Mallee, Salvatore, LeBourdelles, Oliver, Longmore, Koblan (b0430) 2002; 277 Dennis, Fournier, Cadieux, Pomerleau, Jolicoeur, St Pierre, Quirion (b0105) 1990; 254 Lind, Edvinsson (b0390) 2002; 16 Kawasaki (b0310) 2002; 88 Gangula, Supowit, Wimalawansa, Zhao, Hallman, DiPette, Yallampalli (b0210) 1997; 29 Gangula, Zhao, Supowit, Wimalawansa, Dipette, Westlund, Gagel, Yallampalli (b0200) 2000; 35 Köhler, Hoyer (b0345) 2007; 72 Izzo, Sica, Black (b0295) 2008 Lu, Son, Lee, Jetton, Shiota, Moscoso, Niswender, Loewy, Magnuson, Sanes, Emeson (b0405) 1999; 14 Tang, Xu, Yuan, Meng, Cheng, Chen, Liu, Liu, Zhang (b0635) 1989; 102 Amara, Jonas, Rosenfeld, Ong, Evans (b0015) 1982; 298 Edvinsson, Uddman, Wackenfors, Davenport, Longmore, Malmsjo (b0135) 2005; 109 Masuda, Shimamoto, Mori, Nakagawa, Ura, Iimura (b0450) 1992; 10 Schneider, Inscho, Pollock (b0595) 2007; 292 Gennari, Fischer (b0220) 1985; 37 Westermark, Wernstedt, Wilander, Sletten (b0695) 1986; 140 Alevizaki, M., Shiraishi, A., Rassool, F.V., Ferrier, G.J., MacIntyre, I., Legon, S. 1986.The calcitonin-like sequence of the beta CGRP gene. FEBS Lett. 206, 47–52. Hay, Conner, Howitt, Smith, Poyner (b0270) 2004; 22 Uddman, Edvinsson, Ekblad, Hakanson, Sundler (b0665) 1986; 15 Brain, Cox (b0050) 2006; 147 Fisher, Kikkawa, Rivier, Amara, Evans, Rosenfeld, Vale, Brown (b0170) 1983; 305 Manrique, Lastra, Gardner, Sowers (b0435) 2009; 93 Regan, Stump, Kane, Lynch (b0565) 2009; 328 Hay (b0265) 2007; 34 Kirkby, Hadoke, Bagnall, Webb (b0325) 2008; 153 Opitz, Ewert (b0510) 2006; 36 Kittur, Hoppener, Antonarakis (b0335) 1985; 82 Wimalawansa, Morris, Etienne (b0705) 1990; 167 Frezza, Wei, Wachtel (b0190) 2009; 11 Oliver, Wainwright, Edvinsson, Pickard, Hill (b0500) 2002; 22 Steenbergh, Höppener, Zandberg (b0610) 1986; 209 Bowers, Katki, Rao, Koehler, Patel, Spiekerman, DiPette, Supowit (b0030) 2005; 46 Fluhmann, Muff, Hunziker, Fischer, Born (b0180) 1995; 206 Brain, Williams (b0035) 1985; 86 Conner, Hay, Howitt, Kilk, Langel, Wheatley, Smith, Poyner (b0090) 2002; 30 Kallner (b0305) 1998; 49 Maggi (b0420) 1990; 303 Ittner, Luessi, Koller, Born, Fischer, Muff (b0290) 2004; 319 Goadsby, Edvinsson, Ekman (b0245) 1988; 23 Edvinsson, Linde (b0125) 2010; 376 Kurihara, Shindo, Oh-Hashi, Kurihar, Kuwaki (b0350) 2003; 26 Russo (b0580) 2007; 8 Edvinsson, Erlinge, Ekman, Thulin (b0145) 1992; 1 Lackland, Egan (b0365) 2007; 9 Wofford, Hall (b0715) 2004; 10 Howitt, Kilk, Wang, Smith, Langel, Poyner (b0280) 2003; 138 Geppetti, Holzer (b0225) 1996 Mulderry, Ghatei, Spokes (b0470) 1988; 25 Pimenta, Oparil (b0525) 2009; 5 Maggi (b0415) 1991; 11 Steiner, Muff, Gujer, Fischer, Born (b0620) 2002; 41 Aiyar, Rand, Elshourbagy, Zeng, Adamou, Bergsma, Li (b0005) 1996; 271 Gangula, Zhao, Supowit, Wimalawansa, DiPette, Yallampalli (b0205) 1999; 276 Tatasciore, Renda, Zimarino, Soccio, Bilo, Parati, Schillaci, De Caterina (b0640) 2007; 50 Zumpe, Tilakaratne, Fraser, Christopoulos, Foord, Sexton (b0735) 2000; 267 Itabashi, Kashiwabara, Shibuya, Tanaka, Masaoka, Katayama, Ishii (b0285) 1988; 6 Maggi, Meli (b0425) 1988; 19 Udawela, Christopoulos, Morfis, Christopoulos, Ye, Tilakartne (b0660) 2006; 70 Fernandes, Schmidhuber, Brain (b0165) 2009; 194 Wang, Xing, Li, Hou, Guo, Wang (b0675) 2002; 130 Williams, Poulter, Brown, Davis, McInnes, Potter, Sever, MCG (b0700) 2004; 18 Nelson, Huang, Brayden, Hescheler, Standen (b0485) 1990; 344 Kawasaki, Itoh, Kawasaki (b0315) 1998; 21 Li, Peng, Xin, Luo, Zhang, Zhou, Jiang, Deng, Li (b0375) 2008; 29 Lind, Brudlin, Lindholm, Edvinsson (b0395) 1996; 16 Haslam, James (b0260) 2005; 366 Manzini, Bacciarelli (b0440) 1988; 22 Doods, Hallermayer, Wu, Entzeroth, Rudolf, Engel, Eberlein (b0120) 2000; 129 McLatchie, Fraser, Main, Wise, Brown, Thompson, Solari, Lee, Foord (b0455) 1998; 393 Wang, Zhang, Wang (b0685) 2006; 12 Wyon, Frisk, Lundeberg, Theodorsson, Hammar (b0725) 1998; 30 Zimmerman (b0730) 1983; 53 Peng, Li (b0515) 2010; 10 Flahaut, Pfister, Rossier, Firsov (b0175) 2003; 42 Deng, Li (b0100) 2005; 26 Schifter, Krusell, Sehested (b0590) 1991; 4 Ditting, Tiegs, Rodionova, Reeh, Neuhuber, Freisinger, Veelken (b0110) 2009; 297 Edvinsson, Fredholm, Hamel, Jansen, Verrecchia (b0155) 1985; 58 Chiba, Yamaguchi, Yamatani, Nakamura, Morishita, Inui, Fukase, Noda, Fujita (b0085) 1989; 256 Edvinsson (10.1016/j.npep.2010.12.002_b0140) 1998; 19 Sabharwal (10.1016/j.npep.2010.12.002_b0585) 2010; 55 Deng (10.1016/j.npep.2010.12.002_b0100) 2005; 26 Fraser (10.1016/j.npep.2010.12.002_b0185) 1999; 55 Meens (10.1016/j.npep.2010.12.002_b0460) 2009; 331 Brain (10.1016/j.npep.2010.12.002_b0045) 2004; 84 Geppetti (10.1016/j.npep.2010.12.002_b0225) 1996 Manrique (10.1016/j.npep.2010.12.002_b0435) 2009; 93 Kitamura (10.1016/j.npep.2010.12.002_b0330) 1993; 192 Goodman (10.1016/j.npep.2010.12.002_b0250) 1986; 38 Susic (10.1016/j.npep.2010.12.002_b0630) 2008; 5 Thomas (10.1016/j.npep.2010.12.002_b0645) 1994; 171 Lackland (10.1016/j.npep.2010.12.002_b0365) 2007; 9 Conner (10.1016/j.npep.2010.12.002_b0090) 2002; 30 Rovero (10.1016/j.npep.2010.12.002_b0575) 1992; 13 Brain (10.1016/j.npep.2010.12.002_b0050) 2006; 147 Hay (10.1016/j.npep.2010.12.002_b0270) 2004; 22 Oparil (10.1016/j.npep.2010.12.002_b0505) 2003; 139 Wang (10.1016/j.npep.2010.12.002_b0675) 2002; 130 Ando (10.1016/j.npep.2010.12.002_b0020) 1990; 258 Poyner (10.1016/j.npep.2010.12.002_b0545) 2002; 54 Kittur (10.1016/j.npep.2010.12.002_b0335) 1985; 82 Brain (10.1016/j.npep.2010.12.002_b0040) 1986; 87 Maggi (10.1016/j.npep.2010.12.002_b0420) 1990; 303 Wimalawansa (10.1016/j.npep.2010.12.002_b0710) 1996; 17 Gupta (10.1016/j.npep.2010.12.002_b0740) 2008; 11 Maggi (10.1016/j.npep.2010.12.002_b0415) 1991; 11 Chiba (10.1016/j.npep.2010.12.002_b0085) 1989; 256 Juhasz (10.1016/j.npep.2010.12.002_b0300) 2003; 106 Furchgott (10.1016/j.npep.2010.12.002_b0195) 1980; 27 Wyon (10.1016/j.npep.2010.12.002_b0725) 1998; 30 10.1016/j.npep.2010.12.002_b0055 Flahaut (10.1016/j.npep.2010.12.002_b0175) 2003; 42 Ditting (10.1016/j.npep.2010.12.002_b0110) 2009; 297 Kyrou (10.1016/j.npep.2010.12.002_b0360) 2006; 1083 Izzo (10.1016/j.npep.2010.12.002_b0295) 2008 Kurihara (10.1016/j.npep.2010.12.002_b0350) 2003; 26 Edvinsson (10.1016/j.npep.2010.12.002_b0150) 1989; 7 Gangula (10.1016/j.npep.2010.12.002_b0205) 1999; 276 Holzer (10.1016/j.npep.2010.12.002_b0275) 1992; 121 Russo (10.1016/j.npep.2010.12.002_b0580) 2007; 8 Amara (10.1016/j.npep.2010.12.002_b0015) 1982; 298 Goadsby (10.1016/j.npep.2010.12.002_b0240) 1990; 28 Carpenter (10.1016/j.npep.2010.12.002_b0070) 2001; 40 Chan (10.1016/j.npep.2010.12.002_b0080) 2010; 334 Zimmerman (10.1016/j.npep.2010.12.002_b0730) 1983; 53 Portaluppi (10.1016/j.npep.2010.12.002_b0540) 1992; 10 Supowit (10.1016/j.npep.2010.12.002_b0625) 1997; 29 Roh (10.1016/j.npep.2010.12.002_b0570) 2003; 279 Li (10.1016/j.npep.2010.12.002_b0370) 2009; 27 Tsujikawa (10.1016/j.npep.2010.12.002_b0650) 2007; 104 Brain (10.1016/j.npep.2010.12.002_b0035) 1985; 86 Dennis (10.1016/j.npep.2010.12.002_b0105) 1990; 254 Masuda (10.1016/j.npep.2010.12.002_b0450) 1992; 10 Moncada (10.1016/j.npep.2010.12.002_b0465) 1976; 12 Kallner (10.1016/j.npep.2010.12.002_b0305) 1998; 49 Fisher (10.1016/j.npep.2010.12.002_b0170) 1983; 305 Portaluppi (10.1016/j.npep.2010.12.002_b0535) 1993; 10 Sexton (10.1016/j.npep.2010.12.002_b0600) 2009; 14 Li (10.1016/j.npep.2010.12.002_b0380) 2004; 22 Lundberg (10.1016/j.npep.2010.12.002_b0410) 1985; 108 Wimalawansa (10.1016/j.npep.2010.12.002_b0705) 1990; 167 Kuwasako (10.1016/j.npep.2010.12.002_b0355) 2003; 278 Westermark (10.1016/j.npep.2010.12.002_b0695) 1986; 140 Kawasaki (10.1016/j.npep.2010.12.002_b0310) 2002; 88 Howitt (10.1016/j.npep.2010.12.002_b0280) 2003; 138 Maggi (10.1016/j.npep.2010.12.002_b0425) 1988; 19 Kjartansson (10.1016/j.npep.2010.12.002_b0340) 1987; 142 Preibisz (10.1016/j.npep.2010.12.002_b0550) 1993; 6 Wang (10.1016/j.npep.2010.12.002_b0680) 2005; 26 Ittner (10.1016/j.npep.2010.12.002_b0290) 2004; 319 Bowers (10.1016/j.npep.2010.12.002_b0030) 2005; 46 Doods (10.1016/j.npep.2010.12.002_b0120) 2000; 129 Oh-hashi (10.1016/j.npep.2010.12.002_b0490) 2001; 89 Udawela (10.1016/j.npep.2010.12.002_b0660) 2006; 70 Schneider (10.1016/j.npep.2010.12.002_b0595) 2007; 292 Tatasciore (10.1016/j.npep.2010.12.002_b0640) 2007; 50 Qi (10.1016/j.npep.2010.12.002_b0555) 2010; 159 Zumpe (10.1016/j.npep.2010.12.002_b0735) 2000; 267 Wang (10.1016/j.npep.2010.12.002_b0690) 2007; 35 Aiyar (10.1016/j.npep.2010.12.002_b0005) 1996; 271 Edvinsson (10.1016/j.npep.2010.12.002_b0125) 2010; 376 Kawasaki (10.1016/j.npep.2010.12.002_b0320) 1988; 335 Simms (10.1016/j.npep.2010.12.002_b0605) 2009; 41 Uren (10.1016/j.npep.2010.12.002_b0670) 1993; 27 Mallee (10.1016/j.npep.2010.12.002_b0430) 2002; 277 Lu (10.1016/j.npep.2010.12.002_b0405) 1999; 14 Oliver (10.1016/j.npep.2010.12.002_b0500) 2002; 22 Gardiner (10.1016/j.npep.2010.12.002_b0215) 1991; 40 Steenbergh (10.1016/j.npep.2010.12.002_b0610) 1986; 209 Félétou (10.1016/j.npep.2010.12.002_b0160) 2006; 26 Gangula (10.1016/j.npep.2010.12.002_b0210) 1997; 29 Goadsby (10.1016/j.npep.2010.12.002_b0235) 1993; 33 Haslam (10.1016/j.npep.2010.12.002_b0260) 2005; 366 Wang (10.1016/j.npep.2010.12.002_b0685) 2006; 12 Schifter (10.1016/j.npep.2010.12.002_b0590) 1991; 4 Lemne (10.1016/j.npep.2010.12.002_b0745) 1994; 12 Steiner (10.1016/j.npep.2010.12.002_b0615) 2003; 555 Edvinsson (10.1016/j.npep.2010.12.002_b0130) 2010; 30 Uchiyamam (10.1016/j.npep.2010.12.002_b0655) 2008; 13 Wofford (10.1016/j.npep.2010.12.002_b0715) 2004; 10 Wu (10.1016/j.npep.2010.12.002_b0720) 2000; 400 Uddman (10.1016/j.npep.2010.12.002_b0665) 1986; 15 Lindstedt (10.1016/j.npep.2010.12.002_b0400) 2006; 15 10.1016/j.npep.2010.12.002_b0010 Chai (10.1016/j.npep.2010.12.002_b0075) 2006; 531 Nelson (10.1016/j.npep.2010.12.002_b0485) 1990; 344 Gujer (10.1016/j.npep.2010.12.002_b0255) 2001; 40 Goadsby (10.1016/j.npep.2010.12.002_b0245) 1988; 23 Williams (10.1016/j.npep.2010.12.002_b0700) 2004; 18 Pimenta (10.1016/j.npep.2010.12.002_b0525) 2009; 5 Crossman (10.1016/j.npep.2010.12.002_b0095) 1990; 99 Bennett (10.1016/j.npep.2010.12.002_b0025) 1998; 124 Bühlmann (10.1016/j.npep.2010.12.002_b0060) 2000; 486 McLatchie (10.1016/j.npep.2010.12.002_b0455) 1998; 393 Edvinsson (10.1016/j.npep.2010.12.002_b0155) 1985; 58 Márquez-Rodas (10.1016/j.npep.2010.12.002_b0445) 2006; 62 Opitz (10.1016/j.npep.2010.12.002_b0510) 2006; 36 Kirkby (10.1016/j.npep.2010.12.002_b0325) 2008; 153 Lind (10.1016/j.npep.2010.12.002_b0395) 1996; 16 Gangula (10.1016/j.npep.2010.12.002_b0200) 2000; 35 Kawasaki (10.1016/j.npep.2010.12.002_b0315) 1998; 21 Tang (10.1016/j.npep.2010.12.002_b0635) 1989; 102 Hay (10.1016/j.npep.2010.12.002_b0265) 2007; 34 Manzini (10.1016/j.npep.2010.12.002_b0440) 1988; 22 Fernandes (10.1016/j.npep.2010.12.002_b0165) 2009; 194 Lind (10.1016/j.npep.2010.12.002_b0390) 2002; 16 Quirion (10.1016/j.npep.2010.12.002_b0560) 1992; 657 Petermann (10.1016/j.npep.2010.12.002_b0520) 1987; 262 Steiner (10.1016/j.npep.2010.12.002_b0620) 2002; 41 Gennari (10.1016/j.npep.2010.12.002_b0220) 1985; 37 Edvinsson (10.1016/j.npep.2010.12.002_b0135) 2005; 109 Lin (10.1016/j.npep.2010.12.002_b0385) 1991; 254 Edvinsson (10.1016/j.npep.2010.12.002_b0145) 1992; 1 Goadsby (10.1016/j.npep.2010.12.002_b0230) 1994; 117 Djoussé (10.1016/j.npep.2010.12.002_b0115) 2009; 62 Köhler (10.1016/j.npep.2010.12.002_b0345) 2007; 72 (10.1016/j.npep.2010.12.002_b0480) 2006 Burg (10.1016/j.npep.2010.12.002_b0065) 1994; 50 Mulderry (10.1016/j.npep.2010.12.002_b0470) 1988; 25 Peng (10.1016/j.npep.2010.12.002_b0515) 2010; 10 Itabashi (10.1016/j.npep.2010.12.002_b0285) 1988; 6 Olesen (10.1016/j.npep.2010.12.002_b0495) 2004; 350 Fluhmann (10.1016/j.npep.2010.12.002_b0180) 1995; 206 Frezza (10.1016/j.npep.2010.12.002_b0190) 2009; 11 Li (10.1016/j.npep.2010.12.002_b0375) 2008; 29 Mulvany (10.1016/j.npep.2010.12.002_b0475) 1990; 70 Regan (10.1016/j.npep.2010.12.002_b0565) 2009; 328 |
| References_xml | – volume: 38 start-page: 2169 year: 1986 end-page: 2178 ident: b0250 article-title: Calcitonin gene-related peptide: novel neuropeptide publication-title: Life Sci. – volume: 171 start-page: 101 year: 1994 end-page: 104 ident: b0645 article-title: Neonatal capsaicin treatment in rats results in scratching behavior with skin damage: potential model of non-painful dysesthesia publication-title: Neurosci. Lett. – volume: 26 start-page: 286 year: 2005 end-page: 294 ident: b0680 article-title: The vanilloid receptor and hypertension publication-title: Acta. Pharmacol. Sin. – volume: 192 start-page: 553 year: 1993 end-page: 560 ident: b0330 article-title: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma publication-title: Biochem. Biophys. Res. Commun. – volume: 62 start-page: 603 year: 2009 end-page: 605 ident: b0115 article-title: Alcohol consumption and risk of hypertension: does the type of beverage or drinking pattern matter? publication-title: Revista Española De Cardiología – volume: 138 start-page: 325 year: 2003 end-page: 332 ident: b0280 article-title: The role of the 8–18 helix of CGRP8–37 in mediating high affinity binding to CGRP receptors; coulombic and steric interactions publication-title: Br. J. Pharmacol. – volume: 276 start-page: H284 year: 1999 end-page: H288 ident: b0205 article-title: Pregnancy and steroid hormones enhance the vasodilation responses to CGRP in rats publication-title: Am. J. Physiol. Heart. Circ. Physiol. – volume: 140 start-page: 827 year: 1986 end-page: 831 ident: b0695 article-title: A novel peptide in the calcitonin gene relate peptide family as an ahyloid fibril protein in the endocrine pancrrab publication-title: Biochem. Biophys. Res. Commun. – volume: 50 start-page: 180 year: 1994 end-page: 199 ident: b0065 article-title: Intrathecal capsaicin enhances one-kidney renal wrap hypertension in the rat publication-title: J. Auton. Nerv. Syst. – volume: 279 start-page: 7264 year: 2003 end-page: 7274 ident: b0570 article-title: Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes publication-title: The Journal of Biological Chemistry – volume: 55 start-page: 1054 year: 1999 end-page: 1059 ident: b0185 article-title: The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor publication-title: Mol. Pharmacol. – volume: 34 start-page: 963 year: 2007 end-page: 971 ident: b0265 article-title: What makes a CGRP2 receptor? publication-title: Clin. Exp. Pharmacol. Physiol. – volume: 22 start-page: 105 year: 2004 end-page: 113 ident: b0270 article-title: The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors publication-title: J. Mol. Neurosci. – volume: 4 start-page: 565 year: 1991 end-page: 569 ident: b0590 article-title: Normal serum levels of calcitonin gene-related peptide (CGRP) in mild to moderate essential hypertension publication-title: Am. J. Hypertens. – year: 2008 ident: b0295 article-title: Hypertension Primer: The Essentials of High Blood Pressure, Basic Science, population science and clinical management. 4th Edition – volume: 33 start-page: 48 year: 1993 end-page: 56 ident: b0235 article-title: The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats publication-title: Ann. Neurol. – volume: 14 start-page: 99 year: 1999 end-page: 120 ident: b0405 article-title: Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development publication-title: Mol. Cell. Neurosci. – year: 1996 ident: b0225 article-title: Neurogenic Inflammation – volume: 46 start-page: 51 year: 2005 end-page: 57 ident: b0030 article-title: Role of calcitonin gene-related peptide in hypertension-induced renal damage publication-title: Hypertension – volume: 657 start-page: 88 year: 1992 end-page: 105 ident: b0560 article-title: Characterization of CGRP1 and CGRP 2 receptor subtypes publication-title: Ann. N. Y. Acad. Sci. – volume: 109 start-page: 335 year: 2005 end-page: 342 ident: b0135 article-title: Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect publication-title: Clin. Sci. (Lond) – volume: 29 start-page: 248 year: 1997 end-page: 253 ident: b0210 article-title: Calcitonin gene-related peptide is a depressor in NG-nitro-L-arginine methyl ester-induced hypertension during pregnancy publication-title: Hypertension – volume: 366 start-page: 1197 year: 2005 end-page: 1209 ident: b0260 article-title: Obesity publication-title: Lancet – volume: 17 start-page: 533 year: 1996 end-page: 585 ident: b0710 article-title: Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potential publication-title: Endoc. Rev. – volume: 305 start-page: 534 year: 1983 end-page: 536 ident: b0170 article-title: Stimulation of noradrenergic sympathetic outflow by calcitonin gene- related peptide publication-title: Nature – volume: 8 start-page: 687 year: 2007 end-page: 690 ident: b0580 article-title: Ramping it up: RAMP1 and the implications for migraine publication-title: Pharmacogenomics – volume: 27 start-page: 373 year: 1980 end-page: 376 ident: b0195 article-title: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine publication-title: Nature – volume: 40 start-page: 5392 year: 2001 end-page: 5398 ident: b0255 article-title: Mutations of the asparagine117 residue of a receptor activity-modifying protein 1-dependent human calcitonin gene-related peptide receptor result in selective loss of function publication-title: Biochemistry – volume: 11 start-page: 173 year: 1991 end-page: 208 ident: b0415 article-title: The pharmacology of the efferent function of sensory nerves publication-title: J. Auton. Pharmacol. – volume: 22 start-page: 620 year: 2002 end-page: 629 ident: b0500 article-title: Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature publication-title: J. Cereb. Blood Flow Metab. – volume: 130 start-page: 155 year: 2002 end-page: 162 ident: b0675 article-title: Production and secretion of calcitonin gene-related peptide from human lymphocytes publication-title: J. Neuroimmunol. – reference: Branca, F., Nikogosian, H., Lobstein, T. 2007. The challenge of obesity in the WHO European Region and the Strategies for Response. – volume: 10 start-page: 1499 year: 1992 end-page: 1504 ident: b0450 article-title: Plasma calcitonin gene-related peptide levels in patients with various hypertensive diseases publication-title: J. Hypertens. – volume: 277 start-page: 14294 year: 2002 end-page: 14298 ident: b0430 article-title: Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists publication-title: J. Biol. Chem. – volume: 22 start-page: 1345 year: 2004 end-page: 1349 ident: b0380 article-title: Activation of the renin-angiotensin system in α-calcitonin gene-related peptide/calcitonin gene knockout mice publication-title: J. Hypertens. – volume: 30 start-page: 1233 year: 2010 end-page: 1240 ident: b0130 article-title: Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries publication-title: Cephalalgia – volume: 26 start-page: 1215 year: 2006 end-page: 1225 ident: b0160 article-title: Endothelium-derived hyperpolarizing factor: where are we now? publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 139 start-page: 761 year: 2003 end-page: 776 ident: b0505 article-title: Pathogenesis of hypertension publication-title: Ann. Intern. Med. – volume: 40 start-page: 948 year: 1991 end-page: 951 ident: b0215 article-title: Antagonistic effect of human alpha-calcitonin gene-related peptide (8–37) on regional hemodynamic actions of rat islet amyloid polypeptide in conscious Long-Evans rats publication-title: Diabetes – volume: 18 start-page: 139 year: 2004 end-page: 185 ident: b0700 article-title: Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society publication-title: J. Hum. Hypertens. – volume: 84 start-page: 903 year: 2004 end-page: 934 ident: b0045 article-title: Vascular actions of calcitonin gene-related peptide and adrenomedullin publication-title: Physiol. Rev. – volume: 41 start-page: 11398 year: 2002 end-page: 11404 ident: b0620 article-title: The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor publication-title: Biochemistry – volume: 62 start-page: 45 year: 2006 end-page: 56 ident: b0445 article-title: Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension publication-title: J. Physiol. Biochem. – volume: 35 start-page: 470 year: 2000 ident: b0200 article-title: Increased Blood Pressure in publication-title: Hypertension – volume: 106 start-page: 461 year: 2003 end-page: 470 ident: b0300 article-title: NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release publication-title: Pain – volume: 555 start-page: 285 year: 2003 end-page: 290 ident: b0615 article-title: The function of conserved cysteine residues in the extracellular domain of human receptor-activity-modifying protein publication-title: FEBS Lett. – volume: 25 start-page: 195 year: 1988 end-page: 205 ident: b0470 article-title: Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat publication-title: Neuroscience – volume: 297 start-page: F1427 year: 2009 end-page: F1434 ident: b0110 article-title: Do distinct populations of dorsal root ganglion neurons account for the sensory peptidergic innervation of the kidney? Am publication-title: J. Physiol. Renal Physiol. – volume: 99 start-page: 71 year: 1990 end-page: 76 ident: b0095 article-title: Action of calcitonin gene-related peptide upon bovine vascular endothelial and smooth muscle cells grown in isolation and co-culture publication-title: Br. J. Pharmacol. – volume: 256 start-page: E331 year: 1989 end-page: E335 ident: b0085 article-title: Calcitonin gene-related peptide receptor antagonist human CGRP-(8–37) publication-title: Am. J. Physiol. – volume: 26 start-page: 1676 year: 2005 end-page: 1685 ident: b0100 article-title: Calcitonin gene-related peptide and hypertension publication-title: Peptides – volume: 26 start-page: 105 year: 2003 end-page: 108 ident: b0350 article-title: Targeted disruption of adrenomedullin and alphaCGRP genes reveals their distinct biological roles publication-title: Hypertens. Res. – volume: 86 start-page: 855 year: 1985 end-page: 860 ident: b0035 article-title: Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability publication-title: Br. J. Pharmacol. – volume: 1083 start-page: 77 year: 2006 end-page: 110 ident: b0360 article-title: Stress, visceral obesity, and metabolic complications publication-title: Ann. N. Y. Acad. Sci. – volume: 267 start-page: 368 year: 2000 end-page: 372 ident: b0735 article-title: Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product publication-title: Biochem. Biophys. Res. Commun. – volume: 121 start-page: 49 year: 1992 end-page: 146 ident: b0275 article-title: Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds publication-title: Rev. Physiol. Biochem. Pharmacol. – volume: 70 start-page: 921 year: 1990 end-page: 961 ident: b0475 article-title: Structure and function of small arteries publication-title: Physiol. Rev. – volume: 19 start-page: 1213 year: 1998 end-page: 1225 ident: b0140 article-title: Innervation of the human middle meningeal artery: Immunohistochemistry, ultrastructure, and role of endothelium for vasomotility publication-title: Peptides – year: 2006 ident: b0480 article-title: National Collaborating Centre for Chronic Conditions. Hypertension: management of hypertension in adults in primary care: partial update of NICE Clinical Guideline 18, number 34. 34. – volume: 49 start-page: 1 year: 1998 end-page: 35 ident: b0305 article-title: Release and effects of calcitonin gene-related peptide in myocardial ischaemia publication-title: Scand. Cardiovasc. J. Suppl. – volume: 292 start-page: 1208 year: 2007 end-page: 1214 ident: b0595 article-title: Attenuated vasoconstrictor responses to endothelin in afferent arterioles during a high-salt diet publication-title: Am. J. Physiol. Renal Physiol. – volume: 70 start-page: 1750 year: 2006 end-page: 1760 ident: b0660 article-title: A critical role for the short intracellular C terminus in receptor activity-modifying protein function publication-title: Mol. Pharmacol. – volume: 108 start-page: 315 year: 1985 end-page: 319 ident: b0410 article-title: Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin publication-title: Eur. J. Pharmacol. – volume: 6 start-page: S418 year: 1988 end-page: S420 ident: b0285 article-title: The interaction of calcitonin gene-related peptide with angiotensin II on blood pressure and renin release publication-title: J. Hypertens. Suppl. – volume: 102 start-page: 897 year: 1989 end-page: 901 ident: b0635 article-title: Calcitonin gene-related peptide in the pathogenesis and treatment of hypertension publication-title: Chin. Med. J. (Engl). – volume: 142 start-page: 355 year: 1987 end-page: 358 ident: b0340 article-title: Calcitonin gene-related peptide increases survival of a musculocutaneous critical flap in the rat publication-title: Eur. J. Pharmacol. – volume: 7 start-page: 194 year: 1989 end-page: 195 ident: b0150 article-title: Circulating perivascular dilatory neuropeptides in hypertension publication-title: J. Hypertens. – volume: 55 start-page: 627 year: 2010 end-page: 635 ident: b0585 article-title: Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension publication-title: Hypertension – volume: 5 start-page: 453 year: 2009 end-page: 463 ident: b0525 article-title: Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors publication-title: Vascular Health and Risk Management – volume: 10 start-page: 3621 year: 2004 end-page: 3637 ident: b0715 article-title: Pathophysiology and treatment of obesity hypertension publication-title: Curr. Pharm. Des. – volume: 10 start-page: 1277 year: 1992 end-page: 1284 ident: b0540 article-title: Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension publication-title: J. Hypertens. – volume: 6 start-page: 434 year: 1993 end-page: 450 ident: b0550 article-title: Calcitonin gene-related peptide and regulation of human cardiovascular homeostasis publication-title: Am. J. Hypertens. – volume: 88 start-page: 39 year: 2002 end-page: 43 ident: b0310 article-title: Regulation of vascular function by perivascular calcitonin gene-related peptide-containing nerves publication-title: Jpn. J. Pharmacol. – volume: 262 start-page: 542 year: 1987 end-page: 545 ident: b0520 article-title: Identification in the human central nervous system, pituitary, and thyroid of a novel calcitonin gene-related peptide, and partial amino acid sequence in the spinal cord publication-title: J. Biol. Chem. – volume: 40 start-page: 8317 year: 2001 end-page: 8325 ident: b0070 article-title: Turn structures in CGRP C-terminal analogues promote stable arrangements of key residue side chains publication-title: Biochemistry – volume: 209 start-page: 97 year: 1986 end-page: 103 ident: b0610 article-title: Structure and expression of the human calcitonin/CGRP genes publication-title: FEBS Lett. – volume: 129 start-page: 420 year: 2000 end-page: 423 ident: b0120 article-title: Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist publication-title: Br. J. Pharmacol. – volume: 21 start-page: 235 year: 1998 end-page: 243 ident: b0315 article-title: Reduction in blood pressure with a sodium-reduced, potassium- and magnesium-enriched mineral salt in subjects with mild essential hypertension publication-title: Hypertens. Res. – volume: 271 start-page: 11325 year: 1996 end-page: 11329 ident: b0005 article-title: A cDNA encoding the calcitonin gene-related peptide type 1 receptor publication-title: J. Biol. Chem. – volume: 29 start-page: 945 year: 1997 end-page: 950 ident: b0625 article-title: Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat publication-title: Hypertension – volume: 27 start-page: 1224 year: 2009 end-page: 1232 ident: b0370 article-title: Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension publication-title: J. Hypertens. – volume: 167 start-page: 993 year: 1990 end-page: 1000 ident: b0705 article-title: Isolation, purification and characterization of beta-hCGRP from human spinal cord publication-title: Biochem. Biophys. Res. Commun. – volume: 376 start-page: 645 year: 2010 end-page: 655 ident: b0125 article-title: New drugs in migraine treatment and prophylaxis: telcagepant and topiramate publication-title: Lancet – volume: 14 start-page: 413 year: 2009 end-page: 419 ident: b0600 article-title: Modulating receptor function through RAMPs:can they represent drug targets in themselves? Drug Discov publication-title: Today – volume: 72 start-page: 145 year: 2007 end-page: 150 ident: b0345 article-title: The endothelium-derived hyperpolarizing factor: insights from genetic animal models publication-title: Kidney Int. – volume: 53 start-page: 121 year: 1983 end-page: 130 ident: b0730 article-title: Peripheral neurogenic factors in acute and chronic alterations of arterial pressure publication-title: Circ. Res. – reference: Alevizaki, M., Shiraishi, A., Rassool, F.V., Ferrier, G.J., MacIntyre, I., Legon, S. 1986.The calcitonin-like sequence of the beta CGRP gene. FEBS Lett. 206, 47–52. – volume: 89 start-page: 983 year: 2001 end-page: 990 ident: b0490 article-title: Elevated sympathetic nervous activity in mice deficient in alphaCGRP publication-title: Circ. Res. – volume: 82 start-page: 5064 year: 1985 end-page: 5067 ident: b0335 article-title: Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin, and insulin-like growth factor II publication-title: Proc. Natl. Acad. Sci. USA – volume: 393 start-page: 333 year: 1998 end-page: 339 ident: b0455 article-title: RAMPs regulate the transport and ligand specificity of the calcitonin- receptor-like receptor publication-title: Nature – volume: 42 start-page: 10333 year: 2003 end-page: 10341 ident: b0175 article-title: N-glycosylation and conserved cysteine residues in RAMP3 play a critical role for the functional expression of CLR/RAMP3 adrenomedullin receptor publication-title: Biochemistry – volume: 54 start-page: 233 year: 2002 end-page: 246 ident: b0545 article-title: International Union of Pharmacology:XXXII publication-title: The mammalian calcitonin gene-related peptides, AM, AMY, and calcitonin receptors. Pharmacol. Rev. – volume: 87 start-page: 533 year: 1986 end-page: 536 ident: b0040 article-title: Potent vasodilator activity of calcitonin gene-related peptide in human skin publication-title: J. Invest. Dermatol. – volume: 278 start-page: 22623 year: 2003 end-page: 22630 ident: b0355 article-title: Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity publication-title: J. Biol. Chem. – volume: 15 start-page: 1 year: 1986 end-page: 23 ident: b0665 article-title: Calcitonin gene-related peptide (CGRP); perivascular distribution and vasodilatory effects publication-title: Regul. Pept. – volume: 23 start-page: 193 year: 1988 end-page: 196 ident: b0245 article-title: Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system publication-title: Ann. Neurol. – volume: 328 start-page: 571 year: 2009 end-page: 578 ident: b0565 article-title: Calcitonin gene-related peptide receptor antagonism does not affect the severity of myocardial ischaemia during atrial pacing in dogs with coronary artery stenosis publication-title: J. Pharmacol. Exp. Ther. – volume: 16 start-page: 73 year: 1996 end-page: 82 ident: b0395 article-title: Different levels of sensory neuropeptides (calcitonin gene-related peptide and substance P) during and after exercise in man publication-title: Clin. Physiol. – volume: 194 start-page: 393 year: 2009 end-page: 416 ident: b0165 article-title: Sensory-nerve-derived neuropeptides: possible therapeutic targets publication-title: Handb. Exp. Pharmacol. – volume: 41 start-page: 11398 year: 2009 end-page: 11401 ident: b0605 article-title: Structure function analysis of RAMP1 by alanine mutagenesis publication-title: Biochemistry – volume: 11 start-page: 284 year: 2009 end-page: 288 ident: b0190 article-title: Is surgery the next answer to treat obesity-related hypertension? publication-title: J. Clin. Hypertens. – volume: 16 start-page: 53 year: 2002 end-page: 59 ident: b0390 article-title: Enhanced vasodilator responses to calcitonin gene-related peptode (CGRP) in subcutaneous arteries in human hypertension publication-title: J. Hum. Hypertens. – volume: 50 start-page: 325 year: 2007 end-page: 332 ident: b0640 article-title: Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects publication-title: Hypertension – volume: 531 start-page: 246 year: 2006 end-page: 253 ident: b0075 article-title: The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts publication-title: Eur. J. Pharmacol. – volume: 19 start-page: 1 year: 1988 end-page: 43 ident: b0425 article-title: The sensory-efferent function of capsaicin-sensitive sensory neurons publication-title: Gen. Pharmacol. – volume: 9 start-page: 314 year: 2007 end-page: 319 ident: b0365 article-title: Dietary salt restriction and blood pressure in clinical trials publication-title: Curr. Hypertens. Rep. – volume: 400 start-page: 313 year: 2000 end-page: 319 ident: b0720 article-title: Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptor publication-title: Eur. J. Pharmacol. – volume: 159 start-page: 1059 year: 2010 end-page: 1068 ident: b0555 article-title: Structure-function relationships of the N-terminus of receptor activity-modifying proteins publication-title: Br. J. Pharmacol. – volume: 303 start-page: 157 year: 1990 end-page: 166 ident: b0420 article-title: Capsaicin-sensitive nerves in the gastrointestinal tract publication-title: Arch. Int. Pharmacodyn. Ther. – volume: 147 start-page: 202 year: 2006 end-page: 211 ident: b0050 article-title: Neuropeptides and their receptors: innovative science providing novel therapeutic targets publication-title: Br. J. Pharmacol. – volume: 13 start-page: 271 year: 2008 end-page: 280 ident: b0655 article-title: Association of hypertension with changes in the body mass index of university students publication-title: Environ. Health. Prev. Med. – volume: 12 start-page: 287 year: 2006 end-page: 291 ident: b0685 article-title: Effects of Qindan Capsule on blood pressure, endothelin, calcitonin gene-related peptide and angiotensin- II in spontaneous hypertensive rats publication-title: Chin. J. Integr. Med. – volume: 30 start-page: 451 year: 2002 end-page: 455 ident: b0090 article-title: Interaction of calcitonin-gene-related peptide with its receptors publication-title: Biochem. Soc. Trans. – volume: 35 start-page: 719 year: 2007 end-page: 722 ident: b0690 article-title: Increased plasma vasoactive substances and antioxidant enzymes levels in prehypertensive patients publication-title: Zhonghua Xin Xue Guan Bing Za Zhi. – volume: 117 start-page: 427 year: 1994 end-page: 434 ident: b0230 article-title: Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies publication-title: Brain – volume: 15 start-page: 275 year: 2006 end-page: 280 ident: b0400 article-title: Reduced responsiveness of cutaneous microcirculation in essential hypertension-a pilot study publication-title: Blood Press. – volume: 12 start-page: 323 year: 1976 end-page: 335 ident: b0465 article-title: Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition publication-title: Prostaglandins – volume: 334 start-page: 746 year: 2010 end-page: 752 ident: b0080 article-title: Characterization of the CGRP receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries publication-title: J. Pharmacol. Exp. Ther. – volume: 124 start-page: 1573 year: 1998 end-page: 1579 ident: b0025 article-title: Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor publication-title: Br. J. Pharmacol. – volume: 258 start-page: R425 year: 1990 end-page: R429 ident: b0020 article-title: Hemodynamic effects of calcitonin gene-related peptide in spontaneously hypertensive rats publication-title: Am. J. Physiol. – volume: 319 start-page: 1203 year: 2004 end-page: 1209 ident: b0290 article-title: Aspartate publication-title: Biochem. Biophys. Res. Commun. – volume: 22 start-page: 119 year: 1988 ident: b0440 article-title: Enhanced development of deoxycorticosterone-induced hypertension in neonatally capsaicin-pretreated rats publication-title: Regul. Pept. – volume: 104 start-page: 16702 year: 2007 end-page: 16707 ident: b0650 article-title: Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice publication-title: Proc. Natl. Acad. Sci. U S A. – volume: 29 start-page: 1781 year: 2008 end-page: 1788 ident: b0375 article-title: Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats publication-title: Peptides – volume: 1 start-page: 223 year: 1992 end-page: 229 ident: b0145 article-title: Sensory nerve activity in sever hypertension as reflected by circulating calcitonin gene-related peptide (CGRP) and substance P publication-title: Blood Press. – volume: 5 start-page: 104 year: 2008 end-page: 110 ident: b0630 article-title: The aging hypertensive heart: a brief update publication-title: Nat. Clin. Pract. Cardiovasc. Med. – volume: 206 start-page: 341 year: 1995 end-page: 347 ident: b0180 article-title: A human orphan calcitonin receptor-like structure publication-title: Biochem. Biophys. Res. Commun. – volume: 254 start-page: 1022 year: 1991 end-page: 1024 ident: b0385 article-title: Expression cloning of an adenylate cyclase-coupled calcitonin receptor publication-title: Science – volume: 93 start-page: 569 year: 2009 end-page: 582 ident: b0435 article-title: The renin angiotensin aldosterone system in hypertension:role of insulin resistance and oxidative stress publication-title: The Medical Clinics of North America – volume: 27 start-page: 1477 year: 1993 end-page: 1481 ident: b0670 article-title: Effect of intravenous calcitonin gene related peptide on ischaemia threshold and coronary stenosis severity in humans publication-title: Cardiovasc. Res. – volume: 30 start-page: 289 year: 1998 end-page: 294 ident: b0725 article-title: Postmenopausal women with vasomotor symptoms have increased urinary excretion of calcitonin gene-related peptide publication-title: Maturitas – volume: 13 start-page: 1025 year: 1992 end-page: 1027 ident: b0575 article-title: CGRP antagonist activity of short C-terminal fragments of human alpha CGRP, CGRP(23–37) and CGRP(19–37) publication-title: Peptides – volume: 486 start-page: 320 year: 2000 end-page: 324 ident: b0060 article-title: Glycosylation of the calcitonin receptor-like receptor at Asn(60) or Asn(112) is important for cell surface expression publication-title: FEBS Lett. – volume: 12 start-page: 1069 year: 1994 end-page: 1074 ident: b0745 article-title: Increased basal concentrations of plasma endothelin in borderline hypertension publication-title: J. Hypertens. – volume: 331 start-page: 87 year: 2009 end-page: 95 ident: b0460 article-title: Calcitonin gene-related peptide selectively relaxes contractile responses to endothelin-1 in rat mesenteric resistance arteries publication-title: J. Pharmacol. Exp. Ther. – volume: 254 start-page: 123 year: 1990 end-page: 128 ident: b0105 article-title: HCGRP8–37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery publication-title: J. Pharmacol. Exp. Ther. – volume: 28 start-page: 183 year: 1990 end-page: 187 ident: b0240 article-title: Vasoactive peptide release in the extracerebral circulation of humans during migraine headache publication-title: Ann. Nerol. – volume: 36 start-page: 1 year: 2006 end-page: 9 ident: b0510 article-title: Dual ET(A)/ET(B) vs publication-title: Selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension. Eur. J. Clin. Invest. – volume: 10 start-page: 1 year: 2010 end-page: 7 ident: b0515 article-title: The vanilloid receptor TRPV1: role in cardiovascular and gastrointestinal protection publication-title: Eur. J. Pharmacol. – volume: 58 start-page: 213 year: 1985 end-page: 217 ident: b0155 article-title: Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat publication-title: Neurosci. Lett. – volume: 344 start-page: 770 year: 1990 end-page: 773 ident: b0485 article-title: Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels publication-title: Nature – volume: 350 start-page: 1104 year: 2004 end-page: 1110 ident: b0495 article-title: Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine publication-title: N. Engl. J. Med. – volume: 11 start-page: 364 year: 2008 end-page: 372 ident: b0740 article-title: Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks publication-title: Climacteric – volume: 10 start-page: 176 year: 1993 end-page: 189 ident: b0535 article-title: Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach publication-title: Chronobiol. Int. – volume: 37 start-page: 581 year: 1985 end-page: 584 ident: b0220 article-title: Cardiovascular action of calcitonin gene-related peptide in humans publication-title: Calcif. Tissue Int. – volume: 298 start-page: 240 year: 1982 end-page: 244 ident: b0015 article-title: Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products publication-title: Nature – volume: 153 start-page: 1105 year: 2008 end-page: 1119 ident: b0325 article-title: The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? publication-title: Br. J. Pharmacol. – volume: 335 start-page: 164 year: 1988 end-page: 167 ident: b0320 article-title: Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat publication-title: Nature – volume: 29 start-page: 1781 year: 2008 ident: 10.1016/j.npep.2010.12.002_b0375 article-title: Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats publication-title: Peptides doi: 10.1016/j.peptides.2008.06.010 – volume: 531 start-page: 246 year: 2006 ident: 10.1016/j.npep.2010.12.002_b0075 article-title: The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2005.12.039 – volume: 400 start-page: 313 year: 2000 ident: 10.1016/j.npep.2010.12.002_b0720 article-title: Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptor publication-title: Eur. J. Pharmacol. doi: 10.1016/S0014-2999(00)00407-6 – volume: 11 start-page: 364 year: 2008 ident: 10.1016/j.npep.2010.12.002_b0740 article-title: Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks publication-title: Climacteric doi: 10.1080/13697130802378493 – volume: 142 start-page: 355 year: 1987 ident: 10.1016/j.npep.2010.12.002_b0340 article-title: Calcitonin gene-related peptide increases survival of a musculocutaneous critical flap in the rat publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(87)90073-2 – volume: 72 start-page: 145 year: 2007 ident: 10.1016/j.npep.2010.12.002_b0345 article-title: The endothelium-derived hyperpolarizing factor: insights from genetic animal models publication-title: Kidney Int. doi: 10.1038/sj.ki.5002303 – volume: 14 start-page: 99 year: 1999 ident: 10.1016/j.npep.2010.12.002_b0405 article-title: Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development publication-title: Mol. Cell. Neurosci. doi: 10.1006/mcne.1999.0767 – volume: 36 start-page: 1 year: 2006 ident: 10.1016/j.npep.2010.12.002_b0510 article-title: Dual ET(A)/ET(B) vs publication-title: Selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension. Eur. J. Clin. Invest. – volume: 41 start-page: 11398 year: 2009 ident: 10.1016/j.npep.2010.12.002_b0605 article-title: Structure function analysis of RAMP1 by alanine mutagenesis publication-title: Biochemistry – volume: 40 start-page: 8317 year: 2001 ident: 10.1016/j.npep.2010.12.002_b0070 article-title: Turn structures in CGRP C-terminal analogues promote stable arrangements of key residue side chains publication-title: Biochemistry doi: 10.1021/bi0102860 – volume: 1 start-page: 223 year: 1992 ident: 10.1016/j.npep.2010.12.002_b0145 article-title: Sensory nerve activity in sever hypertension as reflected by circulating calcitonin gene-related peptide (CGRP) and substance P publication-title: Blood Press. doi: 10.3109/08037059209077667 – volume: 344 start-page: 770 year: 1990 ident: 10.1016/j.npep.2010.12.002_b0485 article-title: Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels publication-title: Nature doi: 10.1038/344770a0 – volume: 1083 start-page: 77 year: 2006 ident: 10.1016/j.npep.2010.12.002_b0360 article-title: Stress, visceral obesity, and metabolic complications publication-title: Ann. N. Y. Acad. Sci. doi: 10.1196/annals.1367.008 – volume: 331 start-page: 87 year: 2009 ident: 10.1016/j.npep.2010.12.002_b0460 article-title: Calcitonin gene-related peptide selectively relaxes contractile responses to endothelin-1 in rat mesenteric resistance arteries publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.109.155143 – volume: 82 start-page: 5064 year: 1985 ident: 10.1016/j.npep.2010.12.002_b0335 article-title: Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin, and insulin-like growth factor II publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.82.15.5064 – volume: 84 start-page: 903 year: 2004 ident: 10.1016/j.npep.2010.12.002_b0045 article-title: Vascular actions of calcitonin gene-related peptide and adrenomedullin publication-title: Physiol. Rev. doi: 10.1152/physrev.00037.2003 – volume: 209 start-page: 97 year: 1986 ident: 10.1016/j.npep.2010.12.002_b0610 article-title: Structure and expression of the human calcitonin/CGRP genes publication-title: FEBS Lett. doi: 10.1016/0014-5793(86)81091-2 – volume: 62 start-page: 45 year: 2006 ident: 10.1016/j.npep.2010.12.002_b0445 article-title: Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension publication-title: J. Physiol. Biochem. doi: 10.1007/BF03165805 – volume: 108 start-page: 315 year: 1985 ident: 10.1016/j.npep.2010.12.002_b0410 article-title: Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(85)90456-X – volume: 376 start-page: 645 year: 2010 ident: 10.1016/j.npep.2010.12.002_b0125 article-title: New drugs in migraine treatment and prophylaxis: telcagepant and topiramate publication-title: Lancet doi: 10.1016/S0140-6736(10)60323-6 – volume: 38 start-page: 2169 year: 1986 ident: 10.1016/j.npep.2010.12.002_b0250 article-title: Calcitonin gene-related peptide: novel neuropeptide publication-title: Life Sci. doi: 10.1016/0024-3205(86)90568-0 – volume: 267 start-page: 368 year: 2000 ident: 10.1016/j.npep.2010.12.002_b0735 article-title: Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1999.1943 – volume: 334 start-page: 746 year: 2010 ident: 10.1016/j.npep.2010.12.002_b0080 article-title: Characterization of the CGRP receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.110.165993 – volume: 22 start-page: 1345 year: 2004 ident: 10.1016/j.npep.2010.12.002_b0380 article-title: Activation of the renin-angiotensin system in α-calcitonin gene-related peptide/calcitonin gene knockout mice publication-title: J. Hypertens. doi: 10.1097/01.hjh.0000125409.50839.f1 – volume: 55 start-page: 1054 year: 1999 ident: 10.1016/j.npep.2010.12.002_b0185 article-title: The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor publication-title: Mol. Pharmacol. doi: 10.1124/mol.55.6.1054 – volume: 22 start-page: 620 year: 2002 ident: 10.1016/j.npep.2010.12.002_b0500 article-title: Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature publication-title: J. Cereb. Blood Flow Metab. doi: 10.1097/00004647-200205000-00014 – volume: 27 start-page: 1477 year: 1993 ident: 10.1016/j.npep.2010.12.002_b0670 article-title: Effect of intravenous calcitonin gene related peptide on ischaemia threshold and coronary stenosis severity in humans publication-title: Cardiovasc. Res. doi: 10.1093/cvr/27.8.1477 – year: 2006 ident: 10.1016/j.npep.2010.12.002_b0480 – volume: 8 start-page: 687 year: 2007 ident: 10.1016/j.npep.2010.12.002_b0580 article-title: Ramping it up: RAMP1 and the implications for migraine publication-title: Pharmacogenomics doi: 10.2217/14622416.8.7.687 – volume: 30 start-page: 289 year: 1998 ident: 10.1016/j.npep.2010.12.002_b0725 article-title: Postmenopausal women with vasomotor symptoms have increased urinary excretion of calcitonin gene-related peptide publication-title: Maturitas doi: 10.1016/S0378-5122(98)00047-4 – volume: 17 start-page: 533 year: 1996 ident: 10.1016/j.npep.2010.12.002_b0710 article-title: Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potential publication-title: Endoc. Rev. doi: 10.1210/edrv-17-5-533 – volume: 40 start-page: 948 year: 1991 ident: 10.1016/j.npep.2010.12.002_b0215 article-title: Antagonistic effect of human alpha-calcitonin gene-related peptide (8–37) on regional hemodynamic actions of rat islet amyloid polypeptide in conscious Long-Evans rats publication-title: Diabetes doi: 10.2337/diabetes.40.8.948 – volume: 276 start-page: H284 year: 1999 ident: 10.1016/j.npep.2010.12.002_b0205 article-title: Pregnancy and steroid hormones enhance the vasodilation responses to CGRP in rats publication-title: Am. J. Physiol. Heart. Circ. Physiol. doi: 10.1152/ajpheart.1999.276.1.H284 – volume: 303 start-page: 157 year: 1990 ident: 10.1016/j.npep.2010.12.002_b0420 article-title: Capsaicin-sensitive nerves in the gastrointestinal tract publication-title: Arch. Int. Pharmacodyn. Ther. – ident: 10.1016/j.npep.2010.12.002_b0010 – volume: 19 start-page: 1213 year: 1998 ident: 10.1016/j.npep.2010.12.002_b0140 article-title: Innervation of the human middle meningeal artery: Immunohistochemistry, ultrastructure, and role of endothelium for vasomotility publication-title: Peptides doi: 10.1016/S0196-9781(98)00066-7 – volume: 16 start-page: 53 year: 2002 ident: 10.1016/j.npep.2010.12.002_b0390 article-title: Enhanced vasodilator responses to calcitonin gene-related peptode (CGRP) in subcutaneous arteries in human hypertension publication-title: J. Hum. Hypertens. doi: 10.1038/sj.jhh.1001294 – volume: 26 start-page: 286 year: 2005 ident: 10.1016/j.npep.2010.12.002_b0680 article-title: The vanilloid receptor and hypertension publication-title: Acta. Pharmacol. Sin. doi: 10.1111/j.1745-7254.2005.00057.x – volume: 124 start-page: 1573 year: 1998 ident: 10.1016/j.npep.2010.12.002_b0025 article-title: Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0701986 – volume: 30 start-page: 451 year: 2002 ident: 10.1016/j.npep.2010.12.002_b0090 article-title: Interaction of calcitonin-gene-related peptide with its receptors publication-title: Biochem. Soc. Trans. doi: 10.1042/bst0300451 – volume: 139 start-page: 761 year: 2003 ident: 10.1016/j.npep.2010.12.002_b0505 article-title: Pathogenesis of hypertension publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-139-9-200311040-00011 – volume: 86 start-page: 855 year: 1985 ident: 10.1016/j.npep.2010.12.002_b0035 article-title: Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.1985.tb11107.x – volume: 486 start-page: 320 year: 2000 ident: 10.1016/j.npep.2010.12.002_b0060 article-title: Glycosylation of the calcitonin receptor-like receptor at Asn(60) or Asn(112) is important for cell surface expression publication-title: FEBS Lett. doi: 10.1016/S0014-5793(00)02259-6 – volume: 13 start-page: 1025 year: 1992 ident: 10.1016/j.npep.2010.12.002_b0575 article-title: CGRP antagonist activity of short C-terminal fragments of human alpha CGRP, CGRP(23–37) and CGRP(19–37) publication-title: Peptides doi: 10.1016/0196-9781(92)90067-D – volume: 34 start-page: 963 year: 2007 ident: 10.1016/j.npep.2010.12.002_b0265 article-title: What makes a CGRP2 receptor? publication-title: Clin. Exp. Pharmacol. Physiol. doi: 10.1111/j.1440-1681.2007.04703.x – volume: 167 start-page: 993 year: 1990 ident: 10.1016/j.npep.2010.12.002_b0705 article-title: Isolation, purification and characterization of beta-hCGRP from human spinal cord publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/0006-291X(90)90621-S – volume: 26 start-page: 1215 year: 2006 ident: 10.1016/j.npep.2010.12.002_b0160 article-title: Endothelium-derived hyperpolarizing factor: where are we now? publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.0000217611.81085.c5 – volume: 159 start-page: 1059 year: 2010 ident: 10.1016/j.npep.2010.12.002_b0555 article-title: Structure-function relationships of the N-terminus of receptor activity-modifying proteins publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.2009.00541.x – volume: 140 start-page: 827 year: 1986 ident: 10.1016/j.npep.2010.12.002_b0695 article-title: A novel peptide in the calcitonin gene relate peptide family as an ahyloid fibril protein in the endocrine pancrrab publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/0006-291X(86)90708-4 – volume: 40 start-page: 5392 year: 2001 ident: 10.1016/j.npep.2010.12.002_b0255 article-title: Mutations of the asparagine117 residue of a receptor activity-modifying protein 1-dependent human calcitonin gene-related peptide receptor result in selective loss of function publication-title: Biochemistry doi: 10.1021/bi002497v – volume: 11 start-page: 284 year: 2009 ident: 10.1016/j.npep.2010.12.002_b0190 article-title: Is surgery the next answer to treat obesity-related hypertension? publication-title: J. Clin. Hypertens. doi: 10.1111/j.1751-7176.2009.00123.x – volume: 87 start-page: 533 year: 1986 ident: 10.1016/j.npep.2010.12.002_b0040 article-title: Potent vasodilator activity of calcitonin gene-related peptide in human skin publication-title: J. Invest. Dermatol. doi: 10.1111/1523-1747.ep12455620 – volume: 11 start-page: 173 year: 1991 ident: 10.1016/j.npep.2010.12.002_b0415 article-title: The pharmacology of the efferent function of sensory nerves publication-title: J. Auton. Pharmacol. doi: 10.1111/j.1474-8673.1991.tb00317.x – volume: 42 start-page: 10333 year: 2003 ident: 10.1016/j.npep.2010.12.002_b0175 article-title: N-glycosylation and conserved cysteine residues in RAMP3 play a critical role for the functional expression of CLR/RAMP3 adrenomedullin receptor publication-title: Biochemistry doi: 10.1021/bi0347508 – volume: 27 start-page: 373 year: 1980 ident: 10.1016/j.npep.2010.12.002_b0195 article-title: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine publication-title: Nature doi: 10.1038/288373a0 – volume: 12 start-page: 323 year: 1976 ident: 10.1016/j.npep.2010.12.002_b0465 article-title: Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition publication-title: Prostaglandins doi: 10.1016/0090-6980(76)90014-9 – volume: 23 start-page: 193 year: 1988 ident: 10.1016/j.npep.2010.12.002_b0245 article-title: Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system publication-title: Ann. Neurol. doi: 10.1002/ana.410230214 – volume: 53 start-page: 121 year: 1983 ident: 10.1016/j.npep.2010.12.002_b0730 article-title: Peripheral neurogenic factors in acute and chronic alterations of arterial pressure publication-title: Circ. Res. doi: 10.1161/01.RES.53.2.121 – volume: 29 start-page: 248 year: 1997 ident: 10.1016/j.npep.2010.12.002_b0210 article-title: Calcitonin gene-related peptide is a depressor in NG-nitro-L-arginine methyl ester-induced hypertension during pregnancy publication-title: Hypertension doi: 10.1161/01.HYP.29.1.248 – volume: 54 start-page: 233 year: 2002 ident: 10.1016/j.npep.2010.12.002_b0545 article-title: International Union of Pharmacology:XXXII publication-title: The mammalian calcitonin gene-related peptides, AM, AMY, and calcitonin receptors. Pharmacol. Rev. – volume: 366 start-page: 1197 year: 2005 ident: 10.1016/j.npep.2010.12.002_b0260 article-title: Obesity publication-title: Lancet doi: 10.1016/S0140-6736(05)67483-1 – volume: 22 start-page: 105 year: 2004 ident: 10.1016/j.npep.2010.12.002_b0270 article-title: The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors publication-title: J. Mol. Neurosci. doi: 10.1385/JMN:22:1-2:105 – volume: 10 start-page: 176 year: 1993 ident: 10.1016/j.npep.2010.12.002_b0535 article-title: Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach publication-title: Chronobiol. Int. doi: 10.3109/07420529309073886 – volume: 262 start-page: 542 year: 1987 ident: 10.1016/j.npep.2010.12.002_b0520 article-title: Identification in the human central nervous system, pituitary, and thyroid of a novel calcitonin gene-related peptide, and partial amino acid sequence in the spinal cord publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)75816-5 – volume: 393 start-page: 333 year: 1998 ident: 10.1016/j.npep.2010.12.002_b0455 article-title: RAMPs regulate the transport and ligand specificity of the calcitonin- receptor-like receptor publication-title: Nature doi: 10.1038/30666 – volume: 25 start-page: 195 year: 1988 ident: 10.1016/j.npep.2010.12.002_b0470 article-title: Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat publication-title: Neuroscience doi: 10.1016/0306-4522(88)90018-8 – volume: 104 start-page: 16702 year: 2007 ident: 10.1016/j.npep.2010.12.002_b0650 article-title: Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice publication-title: Proc. Natl. Acad. Sci. U S A. doi: 10.1073/pnas.0705974104 – volume: 10 start-page: 1 year: 2010 ident: 10.1016/j.npep.2010.12.002_b0515 article-title: The vanilloid receptor TRPV1: role in cardiovascular and gastrointestinal protection publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2009.10.053 – volume: 657 start-page: 88 year: 1992 ident: 10.1016/j.npep.2010.12.002_b0560 article-title: Characterization of CGRP1 and CGRP 2 receptor subtypes publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/j.1749-6632.1992.tb22759.x – volume: 26 start-page: 1676 year: 2005 ident: 10.1016/j.npep.2010.12.002_b0100 article-title: Calcitonin gene-related peptide and hypertension publication-title: Peptides doi: 10.1016/j.peptides.2005.02.002 – volume: 13 start-page: 271 year: 2008 ident: 10.1016/j.npep.2010.12.002_b0655 article-title: Association of hypertension with changes in the body mass index of university students publication-title: Environ. Health. Prev. Med. doi: 10.1007/s12199-008-0040-2 – volume: 58 start-page: 213 year: 1985 ident: 10.1016/j.npep.2010.12.002_b0155 article-title: Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat publication-title: Neurosci. Lett. doi: 10.1016/0304-3940(85)90166-1 – volume: 70 start-page: 921 year: 1990 ident: 10.1016/j.npep.2010.12.002_b0475 article-title: Structure and function of small arteries publication-title: Physiol. Rev. doi: 10.1152/physrev.1990.70.4.921 – volume: 171 start-page: 101 year: 1994 ident: 10.1016/j.npep.2010.12.002_b0645 article-title: Neonatal capsaicin treatment in rats results in scratching behavior with skin damage: potential model of non-painful dysesthesia publication-title: Neurosci. Lett. doi: 10.1016/0304-3940(94)90615-7 – volume: 10 start-page: 1277 year: 1992 ident: 10.1016/j.npep.2010.12.002_b0540 article-title: Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension publication-title: J. Hypertens. doi: 10.1097/00004872-199210000-00017 – year: 1996 ident: 10.1016/j.npep.2010.12.002_b0225 – volume: 319 start-page: 1203 year: 2004 ident: 10.1016/j.npep.2010.12.002_b0290 article-title: Aspartate69of thecalcitonin-like receptoris required for its functional expression together withreceptor-activity-modifying proteins1 and -2 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2004.05.103 – volume: 18 start-page: 139 year: 2004 ident: 10.1016/j.npep.2010.12.002_b0700 article-title: Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society publication-title: J. Hum. Hypertens. doi: 10.1038/sj.jhh.1001683 – volume: 350 start-page: 1104 year: 2004 ident: 10.1016/j.npep.2010.12.002_b0495 article-title: Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa030505 – volume: 9 start-page: 314 year: 2007 ident: 10.1016/j.npep.2010.12.002_b0365 article-title: Dietary salt restriction and blood pressure in clinical trials publication-title: Curr. Hypertens. Rep. doi: 10.1007/s11906-007-0057-8 – volume: 102 start-page: 897 year: 1989 ident: 10.1016/j.npep.2010.12.002_b0635 article-title: Calcitonin gene-related peptide in the pathogenesis and treatment of hypertension publication-title: Chin. Med. J. (Engl). – volume: 46 start-page: 51 year: 2005 ident: 10.1016/j.npep.2010.12.002_b0030 article-title: Role of calcitonin gene-related peptide in hypertension-induced renal damage publication-title: Hypertension doi: 10.1161/01.HYP.0000168926.44648.ed – volume: 10 start-page: 1499 year: 1992 ident: 10.1016/j.npep.2010.12.002_b0450 article-title: Plasma calcitonin gene-related peptide levels in patients with various hypertensive diseases publication-title: J. Hypertens. doi: 10.1097/00004872-199210120-00010 – volume: 50 start-page: 180 year: 1994 ident: 10.1016/j.npep.2010.12.002_b0065 article-title: Intrathecal capsaicin enhances one-kidney renal wrap hypertension in the rat publication-title: J. Auton. Nerv. Syst. doi: 10.1016/0165-1838(94)90009-4 – volume: 26 start-page: 105 year: 2003 ident: 10.1016/j.npep.2010.12.002_b0350 article-title: Targeted disruption of adrenomedullin and alphaCGRP genes reveals their distinct biological roles publication-title: Hypertens. Res. doi: 10.1291/hypres.26.S105 – volume: 147 start-page: 202 year: 2006 ident: 10.1016/j.npep.2010.12.002_b0050 article-title: Neuropeptides and their receptors: innovative science providing novel therapeutic targets publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0706461 – volume: 335 start-page: 164 year: 1988 ident: 10.1016/j.npep.2010.12.002_b0320 article-title: Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat publication-title: Nature doi: 10.1038/335164a0 – volume: 28 start-page: 183 year: 1990 ident: 10.1016/j.npep.2010.12.002_b0240 article-title: Vasoactive peptide release in the extracerebral circulation of humans during migraine headache publication-title: Ann. Nerol. doi: 10.1002/ana.410280213 – volume: 35 start-page: 719 year: 2007 ident: 10.1016/j.npep.2010.12.002_b0690 article-title: Increased plasma vasoactive substances and antioxidant enzymes levels in prehypertensive patients publication-title: Zhonghua Xin Xue Guan Bing Za Zhi. – volume: 271 start-page: 11325 year: 1996 ident: 10.1016/j.npep.2010.12.002_b0005 article-title: A cDNA encoding the calcitonin gene-related peptide type 1 receptor publication-title: J. Biol. Chem. doi: 10.1074/jbc.271.19.11325 – volume: 29 start-page: 945 year: 1997 ident: 10.1016/j.npep.2010.12.002_b0625 article-title: Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat publication-title: Hypertension doi: 10.1161/01.HYP.29.4.945 – volume: 10 start-page: 3621 year: 2004 ident: 10.1016/j.npep.2010.12.002_b0715 article-title: Pathophysiology and treatment of obesity hypertension publication-title: Curr. Pharm. Des. doi: 10.2174/1381612043382855 – volume: 19 start-page: 1 year: 1988 ident: 10.1016/j.npep.2010.12.002_b0425 article-title: The sensory-efferent function of capsaicin-sensitive sensory neurons publication-title: Gen. Pharmacol. doi: 10.1016/0306-3623(88)90002-X – volume: 33 start-page: 48 year: 1993 ident: 10.1016/j.npep.2010.12.002_b0235 article-title: The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats publication-title: Ann. Neurol. doi: 10.1002/ana.410330109 – volume: 37 start-page: 581 year: 1985 ident: 10.1016/j.npep.2010.12.002_b0220 article-title: Cardiovascular action of calcitonin gene-related peptide in humans publication-title: Calcif. Tissue Int. doi: 10.1007/BF02554909 – volume: 49 start-page: 1 year: 1998 ident: 10.1016/j.npep.2010.12.002_b0305 article-title: Release and effects of calcitonin gene-related peptide in myocardial ischaemia publication-title: Scand. Cardiovasc. J. Suppl. doi: 10.1080/140174398427965 – volume: 62 start-page: 603 year: 2009 ident: 10.1016/j.npep.2010.12.002_b0115 article-title: Alcohol consumption and risk of hypertension: does the type of beverage or drinking pattern matter? publication-title: Revista Española De Cardiología doi: 10.1016/S1885-5857(09)72223-6 – volume: 55 start-page: 627 year: 2010 ident: 10.1016/j.npep.2010.12.002_b0585 article-title: Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.109.148171 – volume: 106 start-page: 461 year: 2003 ident: 10.1016/j.npep.2010.12.002_b0300 article-title: NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release publication-title: Pain doi: 10.1016/j.pain.2003.09.008 – volume: 70 start-page: 1750 year: 2006 ident: 10.1016/j.npep.2010.12.002_b0660 article-title: A critical role for the short intracellular C terminus in receptor activity-modifying protein function publication-title: Mol. Pharmacol. doi: 10.1124/mol.106.024257 – volume: 5 start-page: 104 year: 2008 ident: 10.1016/j.npep.2010.12.002_b0630 article-title: The aging hypertensive heart: a brief update publication-title: Nat. Clin. Pract. Cardiovasc. Med. doi: 10.1038/ncpcardio1091 – volume: 129 start-page: 420 year: 2000 ident: 10.1016/j.npep.2010.12.002_b0120 article-title: Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0703110 – volume: 93 start-page: 569 year: 2009 ident: 10.1016/j.npep.2010.12.002_b0435 article-title: The renin angiotensin aldosterone system in hypertension:role of insulin resistance and oxidative stress publication-title: The Medical Clinics of North America doi: 10.1016/j.mcna.2009.02.014 – ident: 10.1016/j.npep.2010.12.002_b0055 – volume: 6 start-page: S418 year: 1988 ident: 10.1016/j.npep.2010.12.002_b0285 article-title: The interaction of calcitonin gene-related peptide with angiotensin II on blood pressure and renin release publication-title: J. Hypertens. Suppl. doi: 10.1097/00004872-198812040-00131 – volume: 21 start-page: 235 year: 1998 ident: 10.1016/j.npep.2010.12.002_b0315 article-title: Reduction in blood pressure with a sodium-reduced, potassium- and magnesium-enriched mineral salt in subjects with mild essential hypertension publication-title: Hypertens. Res. doi: 10.1291/hypres.21.235 – volume: 15 start-page: 1 year: 1986 ident: 10.1016/j.npep.2010.12.002_b0665 article-title: Calcitonin gene-related peptide (CGRP); perivascular distribution and vasodilatory effects publication-title: Regul. Pept. doi: 10.1016/0167-0115(86)90071-6 – volume: 206 start-page: 341 year: 1995 ident: 10.1016/j.npep.2010.12.002_b0180 article-title: A human orphan calcitonin receptor-like structure publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1995.1047 – volume: 192 start-page: 553 year: 1993 ident: 10.1016/j.npep.2010.12.002_b0330 article-title: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1993.1451 – volume: 555 start-page: 285 year: 2003 ident: 10.1016/j.npep.2010.12.002_b0615 article-title: The function of conserved cysteine residues in the extracellular domain of human receptor-activity-modifying protein publication-title: FEBS Lett. doi: 10.1016/S0014-5793(03)01250-X – volume: 16 start-page: 73 year: 1996 ident: 10.1016/j.npep.2010.12.002_b0395 article-title: Different levels of sensory neuropeptides (calcitonin gene-related peptide and substance P) during and after exercise in man publication-title: Clin. Physiol. doi: 10.1111/j.1475-097X.1996.tb00557.x – volume: 35 start-page: 470 year: 2000 ident: 10.1016/j.npep.2010.12.002_b0200 article-title: Increased Blood Pressure inα-Calcitonin Gene–Related Peptide/Calcitonin Gene Knockout Mice publication-title: Hypertension doi: 10.1161/01.HYP.35.1.470 – volume: 194 start-page: 393 year: 2009 ident: 10.1016/j.npep.2010.12.002_b0165 article-title: Sensory-nerve-derived neuropeptides: possible therapeutic targets publication-title: Handb. Exp. Pharmacol. doi: 10.1007/978-3-540-79090-7_11 – volume: 99 start-page: 71 year: 1990 ident: 10.1016/j.npep.2010.12.002_b0095 article-title: Action of calcitonin gene-related peptide upon bovine vascular endothelial and smooth muscle cells grown in isolation and co-culture publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.1990.tb14656.x – volume: 278 start-page: 22623 year: 2003 ident: 10.1016/j.npep.2010.12.002_b0355 article-title: Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity publication-title: J. Biol. Chem. doi: 10.1074/jbc.M302571200 – volume: 22 start-page: 119 year: 1988 ident: 10.1016/j.npep.2010.12.002_b0440 article-title: Enhanced development of deoxycorticosterone-induced hypertension in neonatally capsaicin-pretreated rats publication-title: Regul. Pept. doi: 10.1016/0167-0115(88)90339-4 – volume: 50 start-page: 325 year: 2007 ident: 10.1016/j.npep.2010.12.002_b0640 article-title: Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.107.090084 – volume: 12 start-page: 1069 year: 1994 ident: 10.1016/j.npep.2010.12.002_b0745 article-title: Increased basal concentrations of plasma endothelin in borderline hypertension publication-title: J. Hypertens. doi: 10.1097/00004872-199409000-00012 – volume: 130 start-page: 155 year: 2002 ident: 10.1016/j.npep.2010.12.002_b0675 article-title: Production and secretion of calcitonin gene-related peptide from human lymphocytes publication-title: J. Neuroimmunol. doi: 10.1016/S0165-5728(02)00221-7 – volume: 121 start-page: 49 year: 1992 ident: 10.1016/j.npep.2010.12.002_b0275 article-title: Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds publication-title: Rev. Physiol. Biochem. Pharmacol. doi: 10.1007/BFb0033194 – volume: 5 start-page: 453 year: 2009 ident: 10.1016/j.npep.2010.12.002_b0525 article-title: Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors publication-title: Vascular Health and Risk Management – volume: 328 start-page: 571 year: 2009 ident: 10.1016/j.npep.2010.12.002_b0565 article-title: Calcitonin gene-related peptide receptor antagonism does not affect the severity of myocardial ischaemia during atrial pacing in dogs with coronary artery stenosis publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.108.144220 – volume: 27 start-page: 1224 year: 2009 ident: 10.1016/j.npep.2010.12.002_b0370 article-title: Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension publication-title: J. Hypertens. doi: 10.1097/HJH.0b013e328329bbd7 – volume: 41 start-page: 11398 year: 2002 ident: 10.1016/j.npep.2010.12.002_b0620 article-title: The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor publication-title: Biochemistry doi: 10.1021/bi020279r – volume: 254 start-page: 123 year: 1990 ident: 10.1016/j.npep.2010.12.002_b0105 article-title: HCGRP8–37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery publication-title: J. Pharmacol. Exp. Ther. doi: 10.1016/S0022-3565(25)12587-1 – volume: 297 start-page: F1427 year: 2009 ident: 10.1016/j.npep.2010.12.002_b0110 article-title: Do distinct populations of dorsal root ganglion neurons account for the sensory peptidergic innervation of the kidney? Am publication-title: J. Physiol. Renal Physiol. doi: 10.1152/ajprenal.90599.2008 – volume: 279 start-page: 7264 year: 2003 ident: 10.1016/j.npep.2010.12.002_b0570 article-title: Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes publication-title: The Journal of Biological Chemistry doi: 10.1074/jbc.M305332200 – volume: 4 start-page: 565 year: 1991 ident: 10.1016/j.npep.2010.12.002_b0590 article-title: Normal serum levels of calcitonin gene-related peptide (CGRP) in mild to moderate essential hypertension publication-title: Am. J. Hypertens. doi: 10.1093/ajh/4.7.565 – volume: 89 start-page: 983 year: 2001 ident: 10.1016/j.npep.2010.12.002_b0490 article-title: Elevated sympathetic nervous activity in mice deficient in alphaCGRP publication-title: Circ. Res. doi: 10.1161/hh2301.100812 – volume: 298 start-page: 240 year: 1982 ident: 10.1016/j.npep.2010.12.002_b0015 article-title: Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products publication-title: Nature doi: 10.1038/298240a0 – volume: 138 start-page: 325 year: 2003 ident: 10.1016/j.npep.2010.12.002_b0280 article-title: The role of the 8–18 helix of CGRP8–37 in mediating high affinity binding to CGRP receptors; coulombic and steric interactions publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0705040 – volume: 258 start-page: R425 year: 1990 ident: 10.1016/j.npep.2010.12.002_b0020 article-title: Hemodynamic effects of calcitonin gene-related peptide in spontaneously hypertensive rats publication-title: Am. J. Physiol. – volume: 277 start-page: 14294 year: 2002 ident: 10.1016/j.npep.2010.12.002_b0430 article-title: Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109661200 – volume: 14 start-page: 413 year: 2009 ident: 10.1016/j.npep.2010.12.002_b0600 article-title: Modulating receptor function through RAMPs:can they represent drug targets in themselves? Drug Discov publication-title: Today – volume: 88 start-page: 39 year: 2002 ident: 10.1016/j.npep.2010.12.002_b0310 article-title: Regulation of vascular function by perivascular calcitonin gene-related peptide-containing nerves publication-title: Jpn. J. Pharmacol. doi: 10.1254/jjp.88.39 – volume: 7 start-page: 194 year: 1989 ident: 10.1016/j.npep.2010.12.002_b0150 article-title: Circulating perivascular dilatory neuropeptides in hypertension publication-title: J. Hypertens. doi: 10.1097/00004872-198900076-00093 – volume: 30 start-page: 1233 year: 2010 ident: 10.1016/j.npep.2010.12.002_b0130 article-title: Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries publication-title: Cephalalgia doi: 10.1177/0333102410362122 – volume: 254 start-page: 1022 year: 1991 ident: 10.1016/j.npep.2010.12.002_b0385 article-title: Expression cloning of an adenylate cyclase-coupled calcitonin receptor publication-title: Science doi: 10.1126/science.1658940 – volume: 305 start-page: 534 year: 1983 ident: 10.1016/j.npep.2010.12.002_b0170 article-title: Stimulation of noradrenergic sympathetic outflow by calcitonin gene- related peptide publication-title: Nature doi: 10.1038/305534a0 – volume: 292 start-page: 1208 year: 2007 ident: 10.1016/j.npep.2010.12.002_b0595 article-title: Attenuated vasoconstrictor responses to endothelin in afferent arterioles during a high-salt diet publication-title: Am. J. Physiol. Renal Physiol. doi: 10.1152/ajprenal.00280.2006 – volume: 117 start-page: 427 year: 1994 ident: 10.1016/j.npep.2010.12.002_b0230 article-title: Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies publication-title: Brain doi: 10.1093/brain/117.3.427 – volume: 15 start-page: 275 year: 2006 ident: 10.1016/j.npep.2010.12.002_b0400 article-title: Reduced responsiveness of cutaneous microcirculation in essential hypertension-a pilot study publication-title: Blood Press. doi: 10.1080/08037050600996586 – year: 2008 ident: 10.1016/j.npep.2010.12.002_b0295 – volume: 256 start-page: E331 year: 1989 ident: 10.1016/j.npep.2010.12.002_b0085 article-title: Calcitonin gene-related peptide receptor antagonist human CGRP-(8–37) publication-title: Am. J. Physiol. – volume: 6 start-page: 434 year: 1993 ident: 10.1016/j.npep.2010.12.002_b0550 article-title: Calcitonin gene-related peptide and regulation of human cardiovascular homeostasis publication-title: Am. J. Hypertens. doi: 10.1093/ajh/6.5.434 – volume: 109 start-page: 335 year: 2005 ident: 10.1016/j.npep.2010.12.002_b0135 article-title: Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect publication-title: Clin. Sci. (Lond) doi: 10.1042/CS20050016 – volume: 153 start-page: 1105 year: 2008 ident: 10.1016/j.npep.2010.12.002_b0325 article-title: The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0707516 – volume: 12 start-page: 287 year: 2006 ident: 10.1016/j.npep.2010.12.002_b0685 article-title: Effects of Qindan Capsule on blood pressure, endothelin, calcitonin gene-related peptide and angiotensin- II in spontaneous hypertensive rats publication-title: Chin. J. Integr. Med. doi: 10.1007/s11655-001-0287-6 |
| SSID | ssj0004288 |
| Score | 2.2747748 |
| SecondaryResourceType | review_article |
| Snippet | Hypertension is still presently the number one “silent killer” in the Western World, and a major risk factor for the development of secondary diseases... Abstract Hypertension is still presently the number one “silent killer” in the Western World, and a major risk factor for the development of secondary diseases... Hypertension is still presently the number one "silent killer" in the Western World, and a major risk factor for the development of secondary diseases... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 93 |
| SubjectTerms | Advanced Basic Science Animals Arterial hypertension. Arterial hypotension Biological and medical sciences Blood and lymphatic vessels Blood Pressure Blood Vessels - physiology Calcitonin Gene-Related Peptide - metabolism Calcitonin Gene-Related Peptide Receptor Antagonists Cardiology. Vascular system Cardiovascular Diseases - etiology CGRP CLR Endocrinology & Metabolism Experimental diseases Fundamental and applied biological sciences. Psychology Human Humans Hypertension Hypertension - complications Hypertension - physiopathology Medical sciences Mouse RAMP1 Rat Receptor Activity-Modifying Proteins - genetics Receptor Activity-Modifying Proteins - metabolism Receptors, Calcitonin Gene-Related Peptide - metabolism Sensory nerves Sensory Receptor Cells - metabolism TRPV1 Vasodilation Vertebrates: endocrinology |
| Title | Calcitonin gene-related peptide (CGRP) and its role in hypertension |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0143417910001150 https://www.clinicalkey.es/playcontent/1-s2.0-S0143417910001150 https://dx.doi.org/10.1016/j.npep.2010.12.002 https://www.ncbi.nlm.nih.gov/pubmed/21269690 https://www.proquest.com/docview/852906801 https://www.proquest.com/docview/858420105 |
| Volume | 45 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9RAEB7a64NCEW3VxuqxDyKKxLtNdnPJ4xGsp4dFisW-LZvNBq-0e6G5Pvji396ZZHOlWE_wKRBm8mMyO_vN5psdgNdyYjDX0UWohRShiMokzBKhQ23KSmLGMdYpFSd_PU5mp-LLmTzbgryvhSFapY_9XUxvo7U_M_LWHNWLxYhoSTH1z-Ie12zDThRniRzAzvTzfHZ8Wx4Zte0nST4kBV8709G8XG3rjuFFq4J-deWe-Wm31g1areraXfwdj7bz0tFjeOQBJZt2z_wEtqzbg_2pw2T68hd7w1qKZ7t2vgcP8r692z7kub4wOJzdwjF0Ihu2VS22ZDXxXErL3uafTr69Y9qVbLFqGNEQGcr-xMT1qqW9L91TOD36-D2fhb6jQmgw4VyFthibzCBS1dVYRroUaZZoiyjBFrLkmmucMeOk0FkcV6nBZCiNS8krkZrIUH-h-BkM3NLZA2CF5HGBcC0pJpWYmCw1nOtCRiaj_WUkD4D3dlTGbzdOXS8uVM8rO1dke0W2VzxSaPsA3q916m6zjY3Scf95VF9GioFP4VywUWtyn5Zt_NhtFFcNSqo__CsAuda846L_vOPwju-sXw3REoY_kQbAemdS6AT0x0Y7u7xuVCppN34EEZtEUkE3kwE87_zw9vo8SrIkG7_4zwc_hIfdCjrxlF7CYHV1bV8hBFsVQ9j-8JsP_UCj4_zkx_wG3FsufA |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcigSQtDyCI_iA0IglO46thPnWEWUBdoKoVbqzbIdRywq3qjZHrjw2xknzlYVZZG4RuM4mYzH30y-8QC8EoXFWEebVHPBU57VeVrmXKfa1o3AiGOqZShOPjrOZ6f805k424BqrIUJtMro-wef3nvreGUStTlp5_NJoCWx0D-LRlxzC25zwYrA69v7dcXzQHwtBx4jS4N4rJwZSF6-de3A7wo5wZhbuWF3utvqDnXWDM0u_o5G-13p4D7ci3CS7A9P_AA2nN-GnX2PofSPn-Q16QmefeZ8G7aqsbnbDlSVPre4mP3cEzQhl_Y1La4mbWC51I68qT58_fKWaF-T-bIjgYRIUPYbhq0XPel94R_C6cH7k2qWxn4KqcVwc5k6M7WlRZyqm6nIdM1lmWuHGMEZUVNNNe6XLDe6ZKyRFkMhyWpBGy5tZkN3IfYINv3CuydAjKDMIFjLTdHwwpbSUqqNyGwZTpcRNAE66lHZeNh46HlxrkZW2XcVdK-C7hXNFOo-gXerMe1w1MZaaTZ-HjUWkaLbU7gTrB1V3DTKdXHldoqqDiXVH9aVgFiNvGag_5xx95rtrF4NsRI6Py4TIKMxKTSC8L9Ge7e47JQU4Sx-hBDrRCQPk4kEHg92eHV_muVlXk6f_ueDv4St2cnRoTr8ePz5GdwZcumBsfQcNpcXl-4FgrGl2e0X22_9ii2k |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Calcitonin+gene-related+peptide+%28CGRP%29+and+its+role+in+hypertension&rft.jtitle=Neuropeptides+%28Edinburgh%29&rft.au=Smillie%2C+Sarah-Jane&rft.au=Brain%2C+Susan+D&rft.date=2011-04-01&rft.eissn=1532-2785&rft.volume=45&rft.issue=2&rft.spage=93&rft_id=info:doi/10.1016%2Fj.npep.2010.12.002&rft_id=info%3Apmid%2F21269690&rft.externalDocID=21269690 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01434179%2FS0143417911X00021%2Fcov150h.gif |